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Abstract
The ergot alkaloids (EAs) are mycotoxins produced by several species of fungi in the genus Claviceps. In
Europe, Claviceps purpurea is the most widespread species and it commonly affects cereals such as rye,
wheat, triticale, barley, millets and oats. Food and feed samples used to estimate human and animal
dietary exposure were analysed for the 12 main C. purpurea EAs: ergometrine, ergosine, ergocornine,
ergotamine, ergocristine, ergocryptine (a- and b-isomers) and their corresponding –inine (S)-epimers.
The highest levels of EAs were reported in rye and rye-containing commodities. In humans, mean
chronic dietary exposure was highest in ‘Toddlers’ and ‘Other children’ with maximum UB estimates of
0.47 and 0.46 lg/kg bw per day, respectively. The 95th percentile exposure was highest in ‘Toddlers’
with a maximum UB estimate of 0.86 lg/kg bw per day. UB estimations were on average fourfold higher
than LB estimations. Average acute exposure (MB estimations) ranged from 0.02 lg/kg bw per day in
‘Infants’ up to 0.32 lg/kg bw per day estimated in ‘Other children’. For the 95th percentile acute
exposure, the highest estimate was for a dietary survey within the age class ‘Other children’ (0.98 lg/kg
bw per day). Dietary exposure estimates for animals, assuming a mean concentration scenario, varied
between 0.31–0.46 lg/kg bw per day in beef cattle and 6.82–8.07 lg/kg bw per day (LB–UB) in piglets,
while exposure estimates assuming a high concentration scenario (95th percentile) varied between
1.43–1.45 lg/kg bw per day and 16.38–16.61 lg/kg bw per day (LB–UB) in the same species. A
statistically signiﬁcant linear relationship between the content of sclerotia and the levels of EAs
quantiﬁed was observed in different crops (barley, oats, rye, triticale and wheat grains). However, the
absence of sclerotia cannot exclude the presence of EAs as samples with no sclerotia identiﬁed showed
measurable levels of EAs (‘false negatives’).
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Summary
The ergot alkaloids (EAs) are mycotoxins produced by several species of fungi in the genus
Claviceps. In Europe, Claviceps purpurea is the most widespread and it commonly affects cereals such
as rye, wheat, triticale, barley, millets and oats. The toxicity of EAs is well known and has been
characterised. The EFSA Panel on Contaminants in the Food Chain (CONTAM) concluded in 2012 that
the vasoconstrictive effect represented by tail muscular atrophy in rats was the critical effect for hazard
characterisation and derivation of the health-based guidance values (HBGVs). A benchmark dose at
10 % extra risk (BMDL10) of 0.33 mg/kg body weight (bw) per day was calculated. A group acute
reference dose (ARfD) of 1 lg/kg bw and a group tolerable daily intake (TDI) of 0.6 lg/kg bw per day
were derived for the sum of the EAs covered in the opinion. Equal relative potency for all EAs was
assumed as the available data did not allow determination of relative potencies (EFSA CONTAM
Panel, 2012).
In an ofﬁcial request from the European Commission in September 2016, the EFSA Evidence
Management Unit (DATA unit) was asked to estimate chronic and acute dietary exposure to EAs in
humans and animals. A total of 4,528 food samples, and 654 feed samples plus 1,235 samples on
grains initially reported as ‘Grain as crops’, were available to estimate dietary exposure. For food, this
number represents more than four times the number of samples used for exposure estimates in the
2012 EFSA opinion. In 97% of the samples, the analysis included all 12 main C.purpurea EAs:
ergometrine, ergosine, ergocornine, ergotamine, ergocristine, ergocryptine (a- and b-isomers) and
their corresponding –inine (S)-epimers. The total content of EAs in each sample was estimated by
summing the reported concentrations for each of the individual alkaloids.
The food samples were collected between 2011 and 2016 in 15 different European countries, with
more than 50% coming from the Netherlands and around 28% from Germany. The highest levels of EAs
were reported in rye and rye-containing commodities, in particular in raw agricultural or minimally
processed commodities (e.g. ‘Rye milling products, 198–239 lg/kg, lower bound (LB)–upper bound
(UB), n = 394). Among processed foods, the highest levels of EAs were found in ‘Mixed wheat and rye
bread and rolls’ (33–82 lg/kg, n = 201), ‘Rye bread and rolls’ (29–67 lg/kg, n = 181) and ‘Rye ﬂakes’
(35–83 lg/kg, n = 15), always for LB–UB scenarios. EA contamination also affects other cereal grains
such as wheat, spelt, oats and corn and their derived processed products; in general, the mean values
were lower than those reported for rye and rye-based products, although the UB scenario was clearly
affected by the left-censored data. In more than three quarters of the food samples (3,463 samples,
76%) all EAs analysed were unquantiﬁed. Among these analytical results reported as left-censored, 74%
were reported as below the limit of quantiﬁcation (LOQ) and the rest as below the limit of detection
(LOD). Only 11% of the analytical results on food were quantiﬁed. The highest average contributors to
the total concentration in each food sample were four EAs, ergotamine (18%), ergocristine (15%),
ergosine (12%) and ergometrine (11%). During processing, the ratio between the average contribution
of the epimeric forms (-ine and -inine) shifts towards the –inine (S)-epimers (from 23.1% to 41.3%).
A total of 654 feed samples were available in the ﬁnal data set. The samples were collected in ﬁve
different countries, the Czech Republic, Croatia, Slovenia, the Netherlands and the United Kingdom
between 2011 and 2016. In more than half of these samples, not a single EA was found above the
LOQ (n = 352). The EAs most commonly quantiﬁed were ergotamine and ergosine (~ 38% of the
samples), with ergometrine and its –inine (S)-epimer only quantiﬁed in 22% and 19% of cases,
respectively. Overall, only 28% of the analytical results were quantiﬁed.
Data for several samples of rye, barley, wheat, oats and triticale grains (n = 1,235) initially reported
as ‘Grain as crops’ (samples of unprocessed grains of unknown end-use) were also available. Around
80% of the samples contained at least one EA above the LOQ, which is a greater proportion than
found for feed samples. When looking at the samples where all 12 EAs were analysed and at least one
EA was quantiﬁed (n = 954), the three predominant EAs in terms of average contribution were
ergotamine (23%), ergosine (19%) and ergocristine (17%). The –ine (R)-epimers represented on
average 75% of the total EA content in each sample, slightly higher than observed in the feed samples
(69%).
Since ‘Grain as crops’ contained higher EA levels as compared to the same grains reported as
feed, the 1,235 samples of ‘Grain as crops’ were combined with the feed samples to cover worst-
case situations and assuming that the samples of ‘Grain as crops’ could end up entering in the feed
chain. In the merged data set most of the samples were unprocessed, mainly cereal grains,
although a few samples of ‘Compound feed’ were also available. The highest EA levels were
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reported for rye grains (LB–UB = 3,019–3,066 lg/kg, n = 192), followed by triticale and wheat grains
with LB–UB = 284–309 lg/kg (n = 115) and LB–UB = 240–265 lg/kg (n = 760), respectively.
The only analytical method reported was liquid chromatography (LC), predominantly with tandem
mass spectrometry (MS/MS) as detection method. Fluorescence detection (FD) was also used in a
minority of cases. The lowest LOQ reported was 0.1 lg/kg but many analytical methods reported
higher LOQs, which had a signiﬁcant impact on the UB due to the amount of left-censored data and
despite the exclusion of results with LOQs higher than 20 lg/kg.
In humans, mean chronic dietary exposure was highest in ‘Toddlers’ and ‘Other children’ with
maximum UB estimates of 0.47 and 0.46 lg/kg bw per day, respectively. The 95th percentile dietary
exposure was highest in ‘Toddlers’ with a maximum UB estimate of 0.86 lg/kg bw per day. Overall,
chronic dietary exposure to EAs in the young population (‘Infants’, ‘Toddlers’, and ‘Other children’) was
2–3 times higher than that estimated for the adult population (‘Adults’, ‘Elderly’, and ‘Very elderly’). UB
estimations were on average 4-fold higher than LB estimations. Among processed foods, the main
contributors to the dietary exposure to EAs were different types of bread and rolls, in particular those
containing or made exclusively of rye, representing up to 84% (middle bound, MB) of the total
exposure to EAs. Average acute exposure (MB) ranged from a minimum of 0.02 lg/kg bw per day
estimated in ‘Infants’ up to a maximum of 0.32 lg/kg bw per day estimated in ‘Other children’. For the
95th percentile acute dietary exposure, the highest estimates were for a dietary survey within the age
class ‘Other children’ (0.98 lg/kg bw per day). For cereal-based processed commodities, the most
relevant foods in terms of acute exposure to EAs were ‘Mixed wheat and rye bread and rolls’ and ‘Rye
bread and rolls’. For high consumers, a single consumption of ‘Mixed wheat and rye bread and rolls’
can lead to acute exposure estimates up to 0.74 (95% CI = 0.59–0.93) lg/kg bw per day and up to
0.64 (95% CI = 0.60–0.69) lg/kg bw per day in the case of ‘Rye bread and rolls’. When compared to
the 2012 EFSA opinion, a higher number of food commodities was available, in particular for processed
foods. This wider range of products probably resulted in higher chronic dietary exposure estimates in
comparison to those from 2012, although also the overall EA content seems to be slightly higher in the
food samples used for the current assessment. Highest acute dietary exposure estimates were similar
to those reported in 2012.
In animal nutrition, compound feeds (complementary or complete feeds) represent a large amount
of the feed consumed by the farmed animals, but the available data on the occurrence of EAs in these
commodities were scarce and did not allow a reliable exposure estimate to be made. Therefore, only
the occurrence data on grain cereals and on forages and roughage were used to calculate animal
exposure. Animal dietary exposure varied according to animal species and productive category.
The exposure considering a mean concentration scenario varied between 0.31–0.46 lg/kg bw per day
in beef cattle and 6.82–8.07 lg/kg bw per day (LB–UB) in piglets, while a high concentration
scenario (95th percentile) resulted in estimates that varied between 1.43–1.45 lg/kg bw per day and
16.38–16.61 lg/kg bw per day (LB–UB) in the same species. When rye is included in the diets, the
exposure of the relevant species would increase up to levels of 25.71–26.47 lg/kg bw per day in the
mean concentration scenario, and up to 67.19–67.26 lg/kg bw per day (LB–UB) in the high
concentration scenario in pigs for fattening, the species with the highest exposure level.
Dietary exposure estimates for EAs have uncertainty related to how representative the food and
feed samples are from across Europe, in particular for feed since data came primarily from a few
countries. The large proportion of left-censored data also gives rise to some uncertainty; this is
particularly relevant for EAs as the ﬁnal content in the samples results from the sum of up to 12
individual compounds, and even more in food samples, where only 11% of the analytical results were
quantiﬁed. Uncertainties related to the consumption data mainly refer to eating occasions reported as
raw agricultural/minimally processed commodities derived from consumption data on processed foods
that were disaggregated. The disaggregated consumption data in these dietary surveys do not specify
the original consumed processed commodity (e.g. cake, bread, etc.) which makes it impossible to
apply any factor to return to the processed commodities. These consumption data were linked to EA
levels in raw agricultural/minimally processed commodities with no factors applied to cover the
possible elimination of EAs during processing. As a result, the dietary exposure estimations obtained
for these dietary surveys are likely overestimated. Related to feed, the use of samples of ‘Grain as
crops’ as feed may imply overestimation of the animal exposure as these samples were reported with
relatively high EA content and their use as feed is not conﬁrmed. Overall, LB estimations of chronic
exposure to EAs most likely underestimated the exposure levels of the European population, while
middle- and, above all, UB exposure are most likely overestimated. Similarly, acute exposure estimates
to EAs are likely overestimated by using the MB scenario.
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Two data providers submitted information on the content of ergot sclerotia in different crops (2,546
results on ergot sclerotia). In total, 638 samples were analysed for both the 12 EAs and the presence
of sclerotia, in most of the cases following sclerotia identiﬁcation. In all crops assessed (barley, oats,
rye, triticale and wheat grains), there was a strong and statistically signiﬁcant (p-value < 0.0001) linear
relationship between the content of sclerotia and the levels of EAs analysed, with Pearson correlation
coefﬁcients ranging between 0.806 for rye grains and 0.972 for triticale grains. It can be concluded
that, in general, the presence of ergot sclerotia is a good indicator for the presence of EAs in grain
samples, with only 14% of samples with sclerotia identiﬁed showing no quantiﬁed levels of EAs (‘false
positives’). However, the absence of sclerotia does not exclude the presence of EAs, since there were
several samples with no sclerotia detected that showed measurable levels of EAs (‘false negatives’).
Efforts should continue to collect analytical data on EAs in relevant food and feed commodities with
special attention to processed foods. Likewise, simultaneous collection of data on the presence of
ergot sclerotia and on the EA content in different food and feed commodities should continue to help
better understand the relationship between these two variables. As the EA pattern of occurrence
seems to depend on many different factors (crop, epimerisation during processing and/or analysis,
etc.), it is recommended to continue monitoring at least the EAs already listed in Commission
Recommendation 2012/154/EU.
Dietary exposure to ergot alkaloids
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1. Introduction
The ergot alkaloids (EAs) are mycotoxins produced by several species of fungi in the genus
Claviceps. In Europe, Claviceps purpurea is the most widespread and it commonly affects cereals such
as rye, wheat, triticale, barley, millets and oats. The fungus has been traditionally associated with rye,
where it forms sclerotia, characteristic dark-coloured crescent-shaped bodies in the ears as a ﬁnal
stage of the plant disease (Krska and Crews, 2008; Mulder et al., 2015).
Figure 1 shows the most important structural features of EAs. This class of alkaloids is
characterised by the presence of a tetracyclic ergoline ring system and can be classiﬁed into four
major groups based on the substitution at C-8: (a) clavine alkaloids and 6,7-secoergolenes (Figure 2),
simple lysergic acid derivatives (Figure 3), ergopeptine alkaloids – cyclol EAs (Figure 4), and
ergopeptam alkaloids – lactam EAs (Figure 5).
NH
HN
A
B
C
D
1 2
3
4
5 6
7
8
9
10
11
12
13
14
15
16
Figure 1: Ergoline ring system including numbering and assignment of rings
Figure 2: Structures exemplifying clavine alkaloids and 6,7 secoergolenes (Figure taken from EFSA
CONTAM Panel 2012)
Figure 3: Structures exemplifying simple lysergic acid alkaloids (Figure taken from EFSA CONTAM
Panel 2012)
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In July 2012, the EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) published a
scientiﬁc opinion on EAs in food and feed. This opinion was based on the EAs identiﬁed in sclerotia of
C. purpurea: ergometrine, ergotamine, ergosine, ergocristine, ergocryptine (which is a mixture of
a- and b-isomers), ergocornine, and the corresponding –inine epimers. These EAs are all ergopeptine
alkaloids (Figure 4), except the lysergic acid derivative ergometrine (Figure 3). The -inine forms are
described to be biologically inactive, but interconversion can occur under various conditions, and thus
the CONTAM Panel based its risk assessment on both forms (-ine and -inine) of ergometrine,
ergotamine, ergosine, ergocristine, a- and b-ergocryptine, and ergocornine.
At the time of the evaluation, only limited occurrence data were available. Around 60% of the food
samples collected were from one Member State and 60% of the samples were left-censored, i.e. below
limit of detection (LOD) or limit of quantiﬁcation (LOQ). Occurrence data on feed were also limited,
with 50% of the data collected in a single Member State and 75% were left censored. The highest
concentrations of EAs were reported for rye grains, rye milling products and rye by-products (EFSA
CONTAM Panel, 2012).
Both chronic and acute exposures for various age groups across European countries were
performed by the CONTAM Panel in 2012. The chronic dietary exposure in the adult population varied
between 0.007 and 0.08 lg/kg body weight (bw) per day for average consumers, and 0.014 and
0.19 lg/kg bw per day for high consumers. The acute dietary exposure in the adult population ranged
between 0.02 and 0.23 lg/kg bw per day for average consumers, and between 0.06 and 0.73 lg/kg
bw per day for high consumers. The highest chronic exposure to EAs in ‘Toddlers’ and ‘Other children’
ranged between 0.03 and 0.17 lg/kg bw per day in ‘Toddlers’, and between 0.02 and 0.17 lg/kg bw
per day in ‘Other children’. For high consumers, estimated chronic exposure values in ‘Toddlers’ ranged
between 0.07 and 0.34 lg/kg bw per day, and for ‘Other children’ between 0.03 and 0.30 lg/kg bw
per day. ‘Toddlers’ and ‘Other children’ showed the highest acute exposure to EAs. For average
consumers, the estimated acute exposure in ‘Toddlers’ ranged between 0.08 and 0.42 lg/kg bw per
day, and between 0.05 and 0.36 lg/kg bw per day in ‘Other children’. For high consumers, estimated
acute exposure values in ‘Toddlers’ ranged between 0.21 and 1.03 lg/kg bw per day, and for ‘Other
children’ between 0.12 and 0.82 lg/kg bw per day. Differences in dietary exposures to EAs were
Figure 4: Structures exemplifying the (cyclol) ergotamine subclass: ergotamine and ergotaminine.
Amino acids involved in the cyclic tripeptide part are shown (Figure taken from EFSA
CONTAM Panel 2012)
Figure 5: Structures exemplifying the (non-cyclol) ergotamam subclass: ergotamam, ergotaminam
and for comparison ergotamine from the cyclol-subclass of ergotamines (Figure taken from
EFSA CONTAM Panel, 2012)
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identiﬁed among countries, with highest both dietary chronic and acute exposures across the different
age groups in countries with high consumption of rye bread and rolls (EFSA CONTAM Panel, 2012).
The toxicity of EAs is well known and characterised from various outbreaks of human poisoning by
grain crops contaminated with sclerotia of fungal species within the genus Claviceps, in particular
C. purpurea (WHO-IPCS, 1990), and the therapeutic use of ergotamine and ergometrine salts. Acute
toxicity, as reﬂected in the LD50s determined in mice, rats and rabbits by intravenous (i.v.) or oral
exposure for EAs was reviewed by the European Food Safety Authority (EFSA) (EFSA, 2005; EFSA
CONTAM Panel, 2012). No-observed-adverse-effect levels (NOAELs) of 0.22–0.60 mg/kg bw per day
were identiﬁed for the toxicity of ergotamine, ergometrine and a-ergocryptine from repeat dose rat
studies. At the doses tested, EAs exhibit moderate oral acute exposure. The acute/short-term toxicity
induces signs of neurotoxicity, including restlessness, miosis or mydriasis, muscular weakness, tremor
and rigidity. EAs act on a number of neurotransmitter receptors, particularly adrenergic, dopaminergic
and serotonergic receptors. The interaction of EAs with neurotransmitter receptors could result in
acute as well as longer term effects. The CONTAM Panel concluded in 2012 that the vasoconstrictive
effect represented by tail muscular atrophy in rats (Speijers et al., 1993) was the critical effect for
hazard characterisation and derivation of the health-based guidance values (HBGVs). A BMDL10 of
0.33 mg/kg bw per day was calculated for the incidence of tail muscular atrophy in a 13-week rat
feeding study of ergotamine. This effect was considered representative of the vasoconstrictive effects
of EAs and provided a suitable reference point for establishment of a group acute reference dose
(ARfD) of 1 lg/kg bw and a group tolerable daily intake (TDI) of 0.6 lg/kg bw per day for the sum of
the EAs covered in the opinion. Equal relative potency for all EAs was assumed as the available data
did not allow determination of relative potencies (EFSA CONTAM Panel, 2012).
The Panel concluded that the available data did not indicate a human health concern for any
population subgroup. However, it was noted that the dietary exposure estimates related to a limited
number of food groups, and a possible unknown contribution from other foods could not be discounted.
Concerning EAs and animal health, EFSA published in 2005 a scientiﬁc opinion related to ergot as
undesirable substance in animal feed. A NOAEL of 0.15 mg EAs/kg feed for piglets and NOAEL of
1.4 mg EAs/kg feed for poultry were observed (EFSA, 2005). In the 2012 opinion, animal exposure to
EAs was calculated by combining feed consumption based on example diets with EAs occurrence levels
in cereal grain data collected by EFSA. However, within the European Union (EU), rye, sorghum and
millet are not widely used as livestock feeds, although where grown commercially, these feeds may be
used more extensively in livestock rations. Furthermore, the risk of ergotism in livestock as a result of
consuming contaminated cereal grains, or compound feeds manufactured from them, is reduced when
appropriate seed cleaning is carried out. Therefore, the Panel concluded that under normal conditions,
the risk of animal health to EAs toxicosis was considered low (EFSA CONTAM Panel, 2012).
EAs as such are not regulated within the EU. A maximum level of 1,000 mg/kg of rye ergot sclerotia
(Claviceps purpurea) in all feed containing unground cereals was set by Directive 2002/32/EC.1 For food,
Commission Regulation (EU) 2015/19402 amended Regulation (EC) No 1881/20063 as regards maximum
levels of ergot sclerotia in certain unprocessed cereals, established a maximum level of 0.5 g/kg of ergot
sclerotia for unprocessed cereals with the exception of corn and rice intended for human consumption.
In order to generate more occurrence data on the presence of EAs in feed and food, the
Commission adopted Recommendation 2012/154/EU4 on the monitoring of the presence of EAs in feed
and food. This monitoring should focus on the six predominant EAs, i.e. ergometrine, ergotamine,
ergosine, ergocristine, ergocryptine and ergocornine and their related –inines. Member States should
measure wherever possible the sclerotia content in the sample in order to improve knowledge with
respect to the relationship between the EAs contained in the sclerotia and in the whole grain.
In September 2016, EFSA received a mandate from the European Commission to perform updated
chronic and acute animal and human exposure assessments to EAs. Furthermore, the Commission
asked to assess the possible relationship between the content of the sclerotia in the samples and the
EA content.
1 OJ L140, 30.5.2002, p. 10.
2 Commission Regulation (EC) No 1940/2015 of 28 October 2015 amending Regulation (EC) 1881/2006 as regards maximum levels
of ergots sclerotia in certain unprocessed cereals and the provisions on monitoring and reporting. OJ L 283, 29.11.2015, p. 3–6.
3 Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in
foodstuffs. OJ L 364, 20.12.2006, p. 5–24.
4 Commission Recommendation 2012/154/EU of 15 March 2012 on the monitoring of the presence of ergot alkaloids in feed and
food (OJ L 77, 16.3.2012, p. 20).
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1.1. Background and Terms of Reference as provided by the requestor
BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION
Following the outcome of EFSA’s scientiﬁc opinion related to ergot as undesirable substance in
animal feed in 20055 and the opinion on ergot alkaloids in food and feed in 2012,6 the Commission
adopted on 15 March 2012 Commission Recommendation 2012/154/EU on the monitoring of the
presence of ergot alkaloids in feed and food4 to collect more occurrence data on ergot alkaloids in
feed and food and to determine, whenever possible, simultaneously the sclerotia content in the sample
in order to improve the knowledge on the relation between the content of sclerotia and of the level of
individual ergot alkaloids.
A maximum level of 1,000 mg/kg of rye ergot (Claviceps purpurea) sclerotia has been established
for feed containing unground cereals by Directive 2002/32/EC of the European Parliament and of the
Council of 7 May 2002 on undesirable substances in animal feed.1 A maximum level of 0.5 g/kg of
ergot sclerotia has been established for unprocessed cereals with the exception of corn and rice
intended for human consumption by Commission Regulation (EC) No 1881/2006 of 19 December 2006
setting maximum levels for certain contaminants in foodstuffs.7
The setting of appropriate and achievable maximum levels for ergot alkaloids, providing a high level
of animal and human health protection shall be considered before 1 July 2017. It is therefore
appropriate to perform an updated chronic and acute animal and human exposure assessment taking
into account the available occurrence data. Furthermore, it is appropriate to assess if there is a
relationship between the content of sclerotia and the level of individual (or sum of) ergot alkaloids.
TERMS OF REFERENCE
In accordance with Article 31 (1) of Regulation (EC) No 178/2002, the Commission asks EFSA for
an updated chronic and acute animal and human exposure assessment to EAs taking into account the
occurrence data available in the EFSA database. In addition, EFSA is requested to assess if there is a
relationship between the content of sclerotia and the level of individual (or sum of) EAs.
2. Data and methodologies
2.1. Data
2.1.1. Occurrence data (food and feed)
2.1.1.1. Data collection and validation
The analytical results on EAs referred to the main Claviceps purpurea EAs that cover a total of 14
different EAs: ergometrine (ergonovine), ergosine, ergocornine, ergotamine, ergocristine, a-
ergocryptine, b-ergocryptine, and the corresponding -inine (S)-epimers (ergometrinine, ergosinine,
ergocorninine, ergotaminine, ergocristinine, a-ergocryptinine and b-ergocryptinine). Analytical data on
the two isomers (a- and b-) of ergocryptine/ergocryptinine were reported either as individual results or
as the sum of both isomers.
At the moment of the closure of the data collection (December 2016), a total of 123,367 analytical
results on EAs were available in the EFSA database (12,675 samples, food and feed). Analytical data
obtained through an Article 36 grant (CFP/EFSA/CONTAM/2010/01) awarded to Ghent University and
already used in the 2012 EFSA opinion were also included (Diana Di Mavungu et al., 2011). In addition
to the data on EAs, a total of 2,546 results on ergot sclerotia were submitted by two different data
providers.
The data were submitted to EFSA following the requirements of the EFSA Guidance on Standard
Sample Description for Food and Feed (EFSA, 2010a).
5 Opinion of the Scientiﬁc Panel on Contaminants in Food Chain on a request from the Commission related to ergot as
undesirable substance in animal feed Available online: https://doi.org/onlinelibrary.wiley.com/doi/10.2903/j.efsa.2005.225/epdf
6 EFSA Panel on Contaminants in the Food Chain (CONTAM); Scientiﬁc Opinion on Ergot alkaloids in food and feed. EFSA Journal
2012;10(7):2798, 158 pp. https://doi.org/10.2903/j.efsa.2012.2798. Available online: https://doi.org/onlinelibrary.wiley.com/
doi/10.2903/j.efsa.2012.2798/epdf
7 OJ L 364, 20.12.2006, p. 5.
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2.1.1.2. Data analysis
To guarantee an appropriate quality of the data used in the exposure assessment, the initial data
set was carefully evaluated by applying several data cleaning and validation steps, including a
comprehensive check of the units and how the results were expressed (e.g. fresh weight/dry weight).
Special attention was paid to the codiﬁcation of food samples under the FoodEx classiﬁcation (EFSA,
2011a) and according to the catalogue of feed materials described in Commission Regulation 68/20138
for the feed samples. The outcome of the data analysis is shown in section 3.
The left-censored data were treated by the substitution method as recommended in the ‘Principles
and Methods for the Risk Assessment of Chemicals in Food’ (WHO/IPCS, 2009). The same method is
indicated in the EFSA scientiﬁc report ‘Management of left-censored data in dietary exposure
assessment of chemical substances’ (EFSA, 2010b) as an option in the treatment of left-censored data.
The guidance suggests that the lower-bound (LB) and upper-bound (UB) approach should be used for
chemicals likely to be present in food (e.g. naturally occurring contaminants, nutrients and
mycotoxins). At the LB, results below the LOQ and LOD were replaced by zero; at the UB, the results
below the LOD were replaced by the LOD and those below the LOQ were replaced by the value
reported as LOQ. Additionally, as a point estimate between the two extremes, the middle-bound (MB)
scenario was calculated by assigning a value of LOD/2 or LOQ/2 to the left-censored data.
2.1.2. Human consumption data
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database)
provides a compilation of national information on food consumption at individual level. It was ﬁrst built in
2010 (EFSA, 2011b; Huybrechts et al., 2011; Merten et al., 2011). Details on how the Comprehensive
Database is used are published in the Guidance of EFSA (EFSA, 2011b). The latest version of the
Comprehensive Database9 contains results from a total of 51 different dietary surveys carried out in 23
different Member States covering 94,532 individuals.
Within the dietary studies, subjects are classiﬁed in different age classes as described in Table 1;
two additional surveys provided information on speciﬁc population groups: ‘Pregnant women’ (Latvia)
and ‘Lactating women’ (Greece).
Overall, the food consumption data in the Comprehensive Database are the most complete and
detailed data currently available at EU level. Consumption data were collected using single or repeated
24- or 48-h dietary recalls, and dietary records covering from 3 to 7 days per subject. Owing to the
differences in the methods used for data collection, direct country-to-country comparisons can be
misleading.
Detailed information on the different dietary surveys used in this report is shown in Appendix A,
including the number of subjects and days available for each age class.
2.1.3. Animal consumption data
The feeds consumed (and the feed intake) by the most relevant farm livestock and companion
animals can only be based on estimates, since no comprehensive feed consumption database exists.
The animal species and categories considered were: (i) ruminants (dairy cows (producing
Table 1: Age classes considered in the EFSA Comprehensive European Food Consumption Database
Age range
Infants < 12 months old
Toddlers ≥ 12 months to < 36 months old
Other children ≥ 36 months to < 10 years old
Adolescents ≥ 10 years to < 18 years old
Adults ≥ 18 years to < 65 years old
Elderly ≥ 65 years to < 75 years old
Very elderly ≥ 75 years old
8 Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials Text with EEA relevance (OJ L
29, 16.1.2013, p. 1).
9 http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb
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approximately 40 kg milk/day)), beef cattle (reared on silage and non-forage feed or cereal based
diets), lactating sheep, milking and fattening goat); (ii) pigs (piglets, fattening pigs and lactating
sows); (iii) poultry (broilers, laying hens, turkeys for fattening and duck for fattening); (iv) rabbits;
(v) farmed ﬁsh; (vi) companion animals (dogs, cats and horses).
The average feed intakes used to calculate animals’ exposure to EAs are described in Appendix B.
They were derived from information extensively described by the CONTAM Panel in two different
Scientiﬁc Opinions on the risks for animal and public health, one on T-2 and HT-2 toxin in food and
feed (EFSA CONTAM Panel, 2011), and the other on EAs in food and feed (EFSA CONTAM Panel,
2012). The estimated feed intakes are based on published guidelines on nutrition and feeding (AFRC,
1993; Carabano and Piquer, 1998; NRC, 2006, 2007a,b; Leeson and Summers, 2008; EFSA, 2009a).
2.1.4. Food classiﬁcation
Data on human consumption and food occurrence were classiﬁed according to the FoodEx
classiﬁcation system (EFSA, 2011a). FoodEx is a food classiﬁcation system developed by EFSA in 2009
with the objective of simplifying the linkage between occurrence and food consumption data when
assessing the exposure to hazardous substances. It contains 20 main food groups (ﬁrst level), which
are further divided into subgroups having 140 items at the second level, 1,261 items at the third level
and reaching about 1,800 end-points (food names or generic food names) at the fourth level.
2.1.5. Feed classiﬁcation
Feed samples were classiﬁed according to the Catalogue of feed materials as described in
Commission Regulation No 68/201310
2.2. Methodologies
2.2.1. Human dietary exposure assessment
Based on the outcome of the EFSA 2012 CONTAM opinion, both chronic and acute dietary exposure
to EAs were assessed (EFSA CONTAM Panel, 2012). In Appendix A, the number of available days for
each age class used in the acute exposure assessment is described beside the number of subjects
available for the chronic exposure assessment.
As suggested by the EFSA Working Group on Food Consumption and Exposure, dietary surveys with
only 1 day per subject were considered only for acute exposure as they are not adequate to assess
repeated exposure (EFSA, 2011b). Similarly, subjects who participated only 1 day in the dietary
studies, when the protocol prescribed more reporting days per individual, were also excluded for the
chronic exposure assessment.
For chronic exposure assessment, food consumption data and body weight were used from 35
different and most recent dietary surveys carried out in 19 different European countries present in the
latest version of the Comprehensive Database. Occurrence data and consumption data were linked at
the lowest FoodEx level possible. The mean and the high (95th percentile) chronic dietary exposures
were calculated by combining EA mean occurrence values with the average daily consumption for each
food at individual level in each dietary survey. Exposure estimates were calculated for each dietary
survey and age class. In addition, the different food commodities were grouped within each food
category to better explain their contribution to the total dietary exposure to EAs.
Acute dietary exposure to EAs was estimated using a probabilistic approach. A total of 41 most
recent dietary surveys carried out in 23 different European countries were used. Acute exposure was
assessed for each reporting day by multiplying the total daily consumption amount for each food by
one occurrence level randomly drawn among the individual results available for that type of food.
Respective exposures from the different foods consumed that day were then summed and ﬁnally
divided by the individual’s body weight. This process was iterated 1,000 times for each reporting day.
For the calculations, the MB approach for the occurrence data was used. For each of these endpoints,
the 95% conﬁdence interval was deﬁned as the 2.5th and 97.5th percentiles obtained from the 1,000
iterations.
10 Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials. OJ L 29, 30.1.2013, p. 1–64.
Dietary exposure to ergot alkaloids
www.efsa.europa.eu/efsajournal 12 EFSA Journal 2017;15(7):4902
2.2.2. Animal dietary exposure assessment
Estimated example diets for each animal species and category were used to calculate the exposure
to EAs. The diets, already presented and extensively described by the CONTAM Panel in the Scientiﬁc
Opinion on T-2 and HT-2 toxin in food and feed (EFSA CONTAM Panel, 2011), are summarised in the
Appendix B. Different scenarios were proposed for ruminant animals: high-yielding dairy cows are
represented by animals with a milk production level of approximately 40 kg/day, with 40% of the dairy
ration as non-forage feed (about 12 kg). Regarding beef cattle, two feeding systems were used one
based on cereals and one on forages.
The cereal grain with the highest probability to be contaminated by EAs is rye. Rye is used in
animal nutrition, even if not in routine like other cereal grains (barley, wheat, maize). Therefore, diets
consisting of rye up to the maximum recommended levels were considered for those species in which
its use is relevant (fattening pigs, lactating sows, laying hens, dairy cows and beef cattle).
2.2.3. Sclerotia content and ergot alkaloid concentration
A correlation analysis was carried out to quantify the strength of a potential linear relationship
between the content of sclerotia and the levels of EAs; a Pearson product-moment correlation
coefﬁcient or Pearson’s correlation was used with a signiﬁcance level (a) of 0.05%.
All analyses were run using the SAS Statistical Software (SAS enterprise guide 5.1), including the
modelling of the probabilistic acute exposure.
3. Assessment
3.1. Occurrence data on ergot alkaloids
The initial data set with 12,675 samples representing 123,367 analytical results on EAs were
collected between 2004 and 2016 in 22 different European countries: Austria, Belgium, Bulgaria,
Croatia, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Italy,
Lithuania, Luxembourg, Malta, Poland, Slovenia, Sweden, Switzerland, the Netherlands, and the United
Kingdom. Although most of the data were submitted by national competent authorities (78%), data
were also reported by academia (Ghent University, 9%) and other providers such as Campden BRI
(7%) and Arvalis - Institut du vegetal (6%).
As a ﬁrst step, 36 grain samples (432 analytical results) were excluded following information
submitted by the data provider on the fact that, due to the high EA levels detected, the samples had
been directed away from the food chain. Likewise, 228 samples (2,686 analytical results) initially
codiﬁed as ‘Bread and rolls’/‘Fine bakery wares’ without further information (FoodEx level 2) were also
excluded following conﬁrmation from the data provider that they referred to baking mixtures and were
not ready-to-eat.
Only data collected in the last ﬁve years were considered. This mainly referred to samples collected
from 2011 to 2015, since only a limited amount of data from samples collected in 2016 were
submitted. Based on this, 2,822 samples (26,331 analytical results) collected between 2004 and 2010
were excluded. A total of 450 analytical results, reporting a value for the generic term ‘Ergot alkaloids’,
were also excluded. There were a total of 376 analytical results for which neither LOQ nor LOD were
submitted, which accounted for a total of 35 samples that were excluded from the ﬁnal data set.
Based on the Standard Sample Description (SSD) data element ‘Sampling strategy’, 1,037 analytical
results (107 samples) reported as ‘Suspect sampling’ were excluded since it was considered that they
did not represent random sampling and they could bias the exposure estimates.
The total content of EAs in each sample was estimated by summing the reported amount for each
of the individual alkaloids reported. Considering the large amount of left-censored data present in the
data set (86%), the presence of relatively high LODs/LOQs may have a signiﬁcant inﬂuence on the UB
scenario. In order to minimise this impact, a careful evaluation was done for each alkaloid reported,
looking at the distribution of the left-censoring limits. A value of 20 lg/kg was selected as a LOQ cut-
off for each of the individual EAs, permitting the exclusion of those samples analysed by methods with
poor sensitivity but without compromising excessively the number of available samples. In total, 8,150
analytical results were excluded (101 quantiﬁed, ~ 1%) that accounted for a total of 1,071 samples.
After this ﬁrst evaluation of the data, a total of 77,301 analytical results was available,
corresponding to 6,458 samples (food and feed). In addition to reporting the generic name ‘Ergot
alkaloid’, the 14 EAs covered in this scientiﬁc report were reported in 17 different ways, considering
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that the two isomers of ergocryptine/ergocryptinine (a- and b-) can be either reported as individual
results or as the sum of both isomers, and that ergometrine was also reported as ergonovine. Based
on literature, it seems that the two isomers of ergocryptinine are not always separated (Crews, 2015).
In fact, in most of the cases, the two isomers were reported as the sum not only for ergocryptinine
but also for ergocryptine. In the very few occasions that both isomers were submitted separately, the
sums for ergocryptine and ergocryptinine were calculated. Likewise, when only one isomer was
reported the analytical result was considered as the sum of both epimers.
To compute the number of EAs reported in each sample, each of the sums of the two isomers were
considered as just one EA, so 12 was considered as the maximum number of ergots reported per
sample: ergometrine, ergosine, ergocornine, ergotamine, ergocristine, ergocryptine (a- and b-
isomers), and their corresponding -inine (S)-epimers. The vast majority of the samples were reported
as analysed for 12 EAs, speciﬁcally 6,255 samples (97%), as a consequence, most probably, of the
Commission Recommendation 2012/154/EU4 that recommended the monitoring of at least the 12 main
C. purpurea EAs (see Section 2.1.1.1). For the remaining ~ 3% of the samples, the number of EAs
analysed varied between 4 and 11.
The contribution of the different alkaloids to the total concentration in each sample was assessed in
those samples with all the 12 EAs reported and at least one quantiﬁed (1,941 samples). Overall, the
average contribution of the –ine (R)-epimers was much higher than that of the –inine (S)-epimers
(72% and 28%). To avoid any potential underestimation in particular food categories by including the
samples that did not report the 12 EAs (3%), only those analysed for at least all –ine (R)-epimers were
included in the ﬁnal data set. At the end, 6,417 samples of food and feed were available to estimate
dietary exposure. The food samples included 1,235 of samples reported as ‘Grain as crops’ (FoodEx
level 2) referring to samples of unprocessed grains of unknown end-use. As later explained in
Section 3.1.2, these samples were treated separately from the food samples.
3.1.1. Occurrence data on food
A total of 4,528 food samples were available in the ﬁnal data set, collected between 2011 and
2016, with almost 70% sampled between 2014 and 2015 (Figure 6). They were collected in 15
different European countries, with more than 50% in the Netherlands and around 28% in Germany.
Figure 7 shows the distribution by sampling country.
2011
2012
2013
2014
2015
2016
Figure 6: Distribution of the food samples included in the ﬁnal data set across sampling years
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The distribution of the number of EAs analysed per sample in the different foods is shown in
Figure 8A. Most of the samples were analysed for the 12 EAs (97%), with a few samples analysed for
6, 10 and 11 EAs. Figure 8B shows the number of times each ergot alkaloid was reported as
quantiﬁed/non quantiﬁed in each of the 4,528 food samples. Ergotamine, ergocristine and ergosine
were quantiﬁed in around 15% of the occasions, while, on the other side, for ergometrinine and
ergocorninine quantiﬁed values were only reported in 6% and 8% of the occasions, respectively.
Overall in the food samples, only 11% of the analytical results were quantiﬁed.
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Figure 7: Distribution of the food samples included in the ﬁnal data set across sampling countries
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Figure 8: (A) Distribution of the number of EAs quantiﬁed per sample in the ﬁnal data set for food;
(B) Number of times each ergot alkaloid was reported as quantiﬁed/non quantiﬁed in the
ﬁnal data set of food samples
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In more than three quarters of the food samples (3,463 samples, 76%), all EAs analysed were
unquantiﬁed. Among these analytical results reported as left-censored, 74% were reported as below
the LOQ and the rest as below the LOD. All samples reported their analytical results expressed as
whole weight.
Among the food samples (excluding samples codiﬁed as ‘Grain as crops’, see Section 3.1.2) with all
12 EAs and at least one quantiﬁed (n = 987), the highest average contributions to the total
concentration in each food sample corresponded to four EAs, namely ergotamine (18%), ergocristine
(15%), ergosine (12%) and ergometrine (11%). When looking separately to unprocessed and
processed foods, some differences were observed. During processing, the ratio between the average
contribution of the epimeric forms (-ine and -inine) shifts towards the –inine (S)-epimers (from 23.1%
to 41.3%). A shift in the epimeric ratio towards the –inine forms during baking has been elsewhere
reported in the literature (Baumann et al., 1985; Wolff et al., 1988; Franzmann et al., 2010; Merkel
et al., 2012). Other relevant differences referred, for instance, to the individual contribution of
particular EAs, with ergometrine and ergometrinine signiﬁcantly increasing their average contribution in
processed food (Table 2). For ergometrinine, a detailed evaluation of the processed foods identiﬁed 27
samples where this EA was the only one quantiﬁed. These samples included rye bread and rolls and
mixed wheat and rye bread and rolls, with also one sample of wheat rolls. Since the samples,
unprocessed and processed, come from different origins, it is difﬁcult to establish a conclusive
relationship between EA composition in the grain and in the processed product. There are numerous
studies in the literature describing the strong inﬂuence of many different factors (environmental
conditions, type of cereal grain, location) on the concentration and the relative proportion of individual
alkaloids in cereals (Miedaner and Geiger, 2015, Coufal-Majewski et al., 2016).
For 19% of the food samples, no information was provided on the analytical method used to
analyse EAs. Where information was submitted, the separation method was always LC with several
detection methods being used (Figure 9). The predominant detection method was tandem mass
spectrometry (MS/MS), either reported without information (LC–MS/MS) or with information on the
analyser used (triple-quadrupole, QqQ) and reported as LC–MS–MS (QqQ). Considering just MS/MS,
this detection method was used for 79% of the samples analysed. The use of single quadrupole mass
spectrometry coupled to LC (LC–MS) was also reported by one data provider (n = 23). For 48 samples,
FD was used, and for 20 samples, only information on the separation method was provided (LC)
without further details on the detection technique.
Table 2: Average contribution of the different EAs to the total concentration in unprocessed and
processed food samples with all the 12 EAs reported and at least one quantiﬁed
n = 987 n = 379 n = 608
Food samples(b) Processed foods Unprocessed foods(b)
Ergometrine 10.9 16.1 7.6
Ergosine(a) 11.6 9.5 12.8
Ergocornine(a) 7.1 4.9 8.4
Ergotamine(a) 18.2 14.9 20.3
Ergocristine(a) 15.3 8.1 19.7
Ergometrinine 6.1 13.3 1.6
Ergosinine 3.5 2.9 3.9
Ergocorninine 3.3 3.8 3.0
Ergotaminine 5.1 5.8 4.8
Ergocristinine 6.9 8.0 6.2
Ergocryptine 6.9 5.0 8.0
Ergocryptinine 5.1 7.5 3.6
-ine (R)-epimers 72.7 58.5 77.1
-inine (S)-epimers 27.3 41.3 23.1
Four selected ergots(a) 57.2 37.4 63.3
(a): Four ergot alkaloids, ergotamine, ergocristine, ergosine and ergocornine indicated in the 2012 EFSA opinion as the most
abundant among the Claviceps purpurea EAs (EFSA CONTAM Panel, 2012).
(b): Samples reported as ‘Grains as crops’ (samples of unprocessed grains of unknown end-use) are not included.
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Since most of the analytical results reported as left-censored were submitted as below the LOQ, the
focus was put on this left-censored limit when describing the sensitivity of the analytical methods.
Table 3 shows the distribution of the reported LOQs in food commodities relevant for the dietary
exposure to EAs. The lowest LOQs (0.1 lg/kg) were reported for both grains and processed grain-
based products such as ‘Grain milling products’, ‘Cereal-based food for infants and young children’, and
‘Breakfast cereals’, using in all cases LC–MS/MS. Although the reported highest sensitivities are in line
with those described in recent literature (Di Mavungu et al., 2012; Crews, 2015), many analytical
methods still reported relatively high LOQs. This has a signiﬁcant impact on the UB estimations when
dealing with left-censored data, even if this inﬂuence on the UB estimations was reduced by excluding
those samples that reported LOQs above 20 lg/kg.
Detailed information is provided in Appendix C on the reported LOQs for each ergot alkaloid in
processed and unprocessed food samples, divided by analytical method; for a better interpretation of
the results the analytical results reported as LC–MS–MS (QqQ) and LC-MS–MS were all considered as
LC-MS–MS. Differences in sensitivity were related to the analytical method rather than to the ergot
alkaloid analysed.
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Figure 9: Information on the analytical methods used for the analysis of EAs in the food samples
Table 3: Distribution of the reported LOQs in the analysis of EAs in selected food commodities
(FoodEx level 2)
Percentiles (lg/kg)
Number of
samples(a)
Number of
observations(b) Min P5 P25 Med P75 P95 Max
Beer and beer-like
beverage
118 996 2 20 20 20 20 20 20
Bread and rolls 583 6,492 0.5 0.8 2 5 10 12.5 20
Breakfast cereals 208 2,487 0.1 2 5 10 20 20 20
Cereal-based food for
infants and young
children
94 1,229 0.1 0.1 0.1 0.1 0.1 2 20
Fine bakery wares 46 548 1 1 1 1 2 10 10
Grain milling products 940 11,256 0.1 1 1 10 15 20 20
Grains and grain-
based products
9 107 1 2 12.5 12.5 15 20 20
Grains for human
consumption
770 9,064 0.1 0.5 2 12.5 15 20 20
Pasta (Raw) 118 1,416 2 2 20 20 20 20 20
Snack food 3 35 2 2 2 2 2 2 2
(a): Number of samples analysed.
(b): Number of observations refers to the individual ergot alkaloids analysed in the food samples.
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Table 4 shows the food samples and their mean EA concentrations used to estimate chronic dietary
exposure once the food groups with only left-censored data were excluded. These samples were
excluded to avoid biasing the exposure estimation by including food categories where EAs are not
expected (e.g. ‘Legumes, nuts and oilseeds’ n = 848, ‘Fruit and fruit products’ n = 437, ‘Fruit and
vegetable juices’ n = 74, ‘Wine’ n = 116) or the reported samples consistently indicate the absence of
ergots (e.g. ‘Beer’ n = 83, ‘Pasta’ n = 118, ‘Muesli’ n = 92). Occurrence data were grouped at the most
appropriate level (Food group) based on EA concentration and number of samples available. Complete
information on the levels of EAs with all the food samples available in the ﬁnal data set (4,528
samples), including those eventually excluded, is given in Appendix D.
Table 4: Mean and 95th percentile concentration (lg/kg) of ergot alkaloids in different food samples as used to estimate
chronic dietary exposure (food groups with all analytical data reported as left-censored are not included)
Mean concentration
(lg/kg)
95th percentile
concentration
(lg/kg)(b),(c)FoodEx level 1 FoodEx level 2 Food group
(a) N %LC(f)
LB MB UB LB MB UB
Grains and
grain-based
products
Grains and grain-based
products
Grains and grain-based
products unspeciﬁed
9 33 245.5 277.2 308.9 – – –
Grains for human
consumption
Wheat grain 248 81 20.0 76.4 132.8 90.3 134.0 240.0
Barley grain 48 79 38.1 46.9 55.8 – – –
Rye grain 321 47 148.7 175.9 203.1 538.4 552.4 579.4
Spelt grain 20 85 28.0 104.2 180.5 – – –
Oats, grain 29 55 32.7 51.7 70.8 – – –
Grain milling products Grain milling products
unspeciﬁed
18 94 12.2 87.2 162.1 – – –
Wheat milling products 293 62 12.0 49.6 87.2 56.9 120.0 240.0
Rye milling products 394 25 198.0 218.7 239.4 818.0 844.0 844.0
Corn milling products 132 99 0.3 114.1 227.9 0.0 120.0 240.0
Oat milling products 14 93 1.9 37.3 72.7 – – –
Spelt milling products 26 77 34.0 91.4 148.8 – – –
Other milling products 35 97 3.3 84.9 166.5 – – –
Bread and rolls Bread and rolls
unspeciﬁed(d)
583 42 24.2 46.1 67.9 104.3 126.0 161.8
Wheat bread and rolls 19 68 5.9 17.6 29.3 – – –
Rye bread and rolls 181 43 29.2 48.0 66.8 134.3 154.5 185.1
Mixed wheat and rye
bread and rolls
201 35 32.8 57.4 82.0 134.2 143.1 171.0
Multigrain bread and rolls 51 33 10.5 18.2 25.9 – – –
Unleavened bread, crisp
bread and rusk
6 50 15.7 41.9 68.1 – – –
Crisp bread, rye
wholemeal
32 53 10.2 30.3 50.4 – – –
Crisp bread, rye, light 62 45 12.9 47.8 82.7 36.7 101.2 159.7
Other bread 22 50 14.0 40.8 67.6 – – –
Bread products 1 0 34.5 73.5 112.4 – – –
Breakfast cereals Cereal ﬂakes
unspeciﬁed(d)
88 86 8.3 46.9 85.6 43.0 120.0 151.6
Mixed cereal ﬂakes 3 0 19.2 19.5 19.8 – – –
Oat ﬂakes(e) 52 92 2.9 51.5 100.1 – – –
Rye ﬂakes(e) 15 73 34.6 59.0 83.4 – – –
Wheat ﬂakes(e) 8 88 1.1 34.6 68.1 – – –
Fine bakery wares Biscuits (cookies) 39 67 2.9 9.8 16.7 – – –
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Nearly all samples used in the exposure estimations belonged to the food group ‘Grains and grain-
based products’ (FoodEx level 1) with only few samples available for the food group ‘Food for infants
and small children’ (Table 4). More than half of the samples referred to raw agricultural commodities
(RAC), in particular grains and minimally processed commodities (i.e. grain milling products). However,
around 800 samples of different grain-based processed products were also available for exposure
estimations, among them ‘Bread and rolls’, ‘Breakfast cereals’, ‘Fine bakery wares’ and ‘Cereal-based
food for infants and young children’. In addition, and as commented above, some other processed
commodities that could be susceptible to contain EAs were excluded as all reported data were left-
censored (e.g. ‘Beer’ n = 83, ‘Pasta’ n = 118, ‘Muesli’ n = 92).
Taking into account the available number of grain-based processed products, the use of factors to
convert the RAC into processed commodities was discarded. The 2012 EFSA scientiﬁc opinion
mentioned that most studies on the effect of baking with EA contaminated ﬂours showed an overall
reduction of EA levels in the ﬁnal product (EFSA CONTAM Panel, 2012). However, these studies are not
conclusive on the magnitude of the reduction beyond the fact that the ratio between the epimeric
forms in general shifts towards the -inine forms. As an example, during baking 54–85% losses are
reported for rye ﬂour bread and 0–100% for wheat ﬂour, with a higher reduction usually in the bread
crust when compared to crumb (Scott, 2009). Likewise, Merkel et al. (2012) also investigated the
degradation and epimerisation of EAs in rye ﬂour after baking cookies, resulting in degradation of EAs
(2–30%) and a shift in the epimeric ratio towards the -inine forms for all EAs. In the reported
occurrence data, it can be seen that among the quantiﬁed samples of ‘Rye milling products’ and ‘Rye
bread and rolls’ there was a reduction factor of ~ 5 in the EA concentrations from 263 to 51 lg/kg.
The observed decreases cannot only be explained by dilution factors related to the recipes used but
must also be due to the effect of baking on the EAs itself.
The group ‘Bread and rolls, unspeciﬁed’ was created considering all samples of bread and rolls to
account for the unspeciﬁed consumption of breads and rolls. Besides this group, the highest number of
samples belongs to grains and grain milling products of rye and wheat (Table 4). Among processed
foods, the most reported commodities were ‘Mixed wheat and rye bread and rolls’ (n = 201) and ‘Rye
bread and rolls’ (n = 181). The food group ‘Breakfast cereals’ was also well represented, with samples
Mean concentration
(lg/kg)
95th percentile
concentration
(lg/kg)(b),(c)FoodEx level 1 FoodEx level 2 Food group
(a) N %LC(f)
LB MB UB LB MB UB
Food for infants
and small
children
Cereal-based food for
infants and young
children
Cereal-based food for
infants and young
children unspeciﬁed
13 92 0.7 20.2 39.8 – – –
Simple cereals which are
or have to be
reconstituted with milk or
other appropriate
nutritious liquids
49 65 6.7 8.4 10.2 – – –
Cereals with an added
high protein food which
are or have to be
reconstituted with water
or other protein-free
liquid
10 80 0.3 3.2 6.1 – – –
Biscuits, rusks and
cookies for children
22 50 11.2 11.6 12.1 – – –
N: number of samples; %LC: percentage of left-censored samples; LB: lower bound; MB: middle bound; UB: upper bound.
(a): The different food commodities were grouped at different levels before estimating dietary exposure: FoodEx level 2 (underlined), FoodEx level 3 (normal),
FoodEx level 4 (italics).
(b): Estimation of 95th percentile is not reliable when less than 60 observations are available.
(c): The 95th percentile estimates equals zero because less than 5% of the samples were quantiﬁed.
(d): Two food categories, ‘Bread and rolls unspeciﬁed’ at FoodEx level 2 and ‘Cereal ﬂakes’ at FoodEx level 3 were created using all the samples available
within each food group to account for unspeciﬁed consumption of these commodities.
(e): The food groups ‘Wheat ﬂakes’, ‘Oat ﬂakes’, ‘Rye ﬂakes’ were created considering all types of ﬂakes reported within each cereal (e.g. ‘Oat ﬂakes’ is made
up of samples reported as ‘Oat ﬂakes’ (n = 46), Oat ﬂakes with fruits’ (n = 2), Oat ﬂakes instant’ (n = 2), Oat ﬂakes, whole meal’ (n = 2)).
(f): A sample was considered as left-censored when not a single EA was quantiﬁed.
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reported with different grain composition, such as oat, rye and wheat ﬂakes. Diverse types of samples
of ‘Cereal-based food for infants and young children’ were also available, including few samples of
‘Biscuits, rusks and cookies for children’ (n = 22).
Overall, and within each particular group, the highest EA mean levels were reported for rye and
rye-containing commodities. The highest mean values were reported for ‘Rye milling products’ with
198–239 lg/kg (LB–UB, n = 394) followed by ‘Rye grains’ with 149–203 lg/kg (LB–UB, n = 321).
Concerning processed foods, similar EA mean levels were reported for different rye-based processed
products, such as ‘Mixed wheat and rye bread and rolls’ (33–82 lg/kg, n = 201), ‘Rye bread and rolls’
(29–67 lg/kg, n = 181) and ‘Rye ﬂakes’ (35–83 lg/kg, n = 15), always for LB–UB scenarios.
As can be seen in Table 4, EA contamination is not only limited to rye, but also affects other cereal
grains such as wheat, spelt, oats and corn and their derived processed products. In general, the mean
values were lower than those reported for rye and rye-based products, e.g. ‘Wheat milling products
(12–87 lg/kg (LB–UB), n = 293), cereal ﬂakes made of oat (3–100 lg/kg (LB–UB), n = 52) or wheat
(1–68 lg/kg (LB–UB), n = 8), although the UB scenario was clearly affected by the left-censored data
and the reported LOQs. Among the samples of ‘Cereal-based food for infants and young children’, the
highest mean values were reported for samples of ‘Biscuits, rusks and cookies for children’ (11–12 lg/kg
(LB–UB), n = 22). The samples in this food group contained, overall, lower levels of EAs than other
grain-based processed products.
3.1.2. Grain as crops
‘Grain as crops’ (FoodEx level 2) refers to samples of unprocessed grains of unknown end-use.
These grains are usually not considered when estimating human dietary exposure, and in particular
occasions they have been combined with the feed samples to cover some feed groups that initially
were not available. This occurred, for instance, in the EFSA 2012 scientiﬁc opinion on EAs with few
samples of barley, rye and wheat (EFSA CONTAM Panel, 2012).
In the current data set, a total of 1,235 samples were reported as ‘Grain as crops’; Figure 10 shows
the different type of grains where ‘Wheat grains’ almost represented half of the total (45%). Among
the different ‘Grain as crops’ the highest mean levels were submitted for rye grains (LB = 3,368 lg/kg,
UB = 3,419 lg/kg), followed by triticale, wheat, barley and oat grains. No EAs were found in rice,
millet and buckwheat grains (Table 5). For almost 80% of the samples, at least one EA was reported
as quantiﬁed, a higher percentage than in feed samples. When looking at the samples with the 12 EAs
analysed and at least one EA quantiﬁed (n = 954), the three predominant EAs in terms of average
contribution were ergotamine (23%), ergosine (19%) and ergocristine (17%). The –ine (R)-epimers
represented on average as much as 75% of the total EA content in each sample.
These grains were collected between 2012 and 2016 from ﬁve different countries, Croatia, the
Czech Republic, France, the Netherlands and the United Kingdom. Most of the samples reported the
12 EAs covered in this report (88%) with the rest being analysed for 11 EAs. All analytical results were
expressed in whole weight.
All crops were analysed by LC–MS/MS or LC–MS. For the samples reporting MS/MS, in certain cases
additional information on the analyser was also provided (QqQ). The highest sensitivity was reported
in samples of wheat and rye with an LOQ of 1 lg/kg for each of the EAs analysed, except for rye
where for ergocryptine (sum of a- and b-isomers) and its -inine form an LOQ of 6 lg/kg was reported.
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3.1.3. Occurrence data on feed
A total of 654 samples of feed were available in the ﬁnal data set; all analytical results were
expressed on a whole weight basis. The samples were collected in ﬁve different countries, the Czech
Republic, Croatia, Slovenia, the Netherlands and the United Kingdom between 2011 and 2016
(Figure 11). All feed samples except one were analysed for all 12 EAs.
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Figure 10: Samples of different grains reported as ‘Grains as crops’ that refer to unprocessed grains
of unknown end-use
Table 5: Summary statistics of the levels of EAs (in lg/kg) in different unprocessed grains of
unknown end-use (‘Grains as crops’)
Percentiles (lg/kg)
N %LC(a) LB/UB Mean (lg/kg)
P5 P25 Median P75 P95
Rice (Crop) 191 100 LB 0 0 0 0 0 0
UB 240 240 240 240 240 240
Oat grain (Crop) 33 70 LB 65 – 0 0 26 –
UB 207 – 120 220 240 –
Millet grain (Crop) 2 100 LB 0 – – – – –
UB 240 – – – – –
Buckwheat grain (Crop) 4 100 LB 0 – – – – –
UB 240 – – – – –
Rye grain (Crop) 171 36 LB 3,368 0 0 120 536 9,843
UB 3,419 36 104 230 556 9,843
Barley grain (Crop) 173 41 LB 115 0 0 16 100 545
UB 201 36 57 135 240 545
Wheat grain (Crop) 559 37 LB 294 0 0 20 121 623
UB 322 12 15 65 151 635
Triticale (crop) 102 25 LB 315 0 0 72 317 1,603
UB 343 36 48 100 327 1,603
N: number of samples; %LC: percentage of left-censored samples; LB: lower bound; UB: upper bound.
(a): A sample was considered as left-censored when not a single EA is quantiﬁed.
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Liquid chromatography was the method of choice when analysing the feed samples with the
predominant detection method being MS/MS. As for food, additional information was sometimes
provided on the MS detector (QqQ). Only one data provider reported the use of LC–MS (n = 7). The
highest sensitivity was 1 lg/kg (LOQ) for both LC–MS and LC–MS/MS. While the few samples analysed
by LC–MS reported an LOQ of 1 lg/kg for each of the EAs analysed, for LC–MS/MS analysis the LOQs
ranged between 1 and 10 lg/kg among the different EAs.
In more than half of the feed samples, no EAs were quantiﬁed (n = 352). The presence of the
different EAs in the feed samples was also analysed. Figure 12 shows the number of times the
different EAs were quantiﬁed/non-quantiﬁed; the EAs most commonly quantiﬁed were ergotamine and
ergosine (~ 38% of the samples) while on the other side ergometrine and its –inine (S)-epimer were
only quantiﬁed in 22% and 19% of the occasions, respectively. Overall, only 28% of the analytical
results were quantiﬁed.
Looking at the samples with all 12 EAs analysed and at least one quantiﬁed (n = 302), the highest
average contributions to the total concentration in each sample were reported for three EAs, namely
ergotamine (21%), ergosine (17%) and ergocristine (13%). Overall, -ine (R)-epimers represented on
average 69% of the total levels of EAs in each sample, with barely differences between raw and
processed feed commodities.
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Figure 12: Number of times each ergot alkaloid was reported as quantiﬁed/non quantiﬁed in the ﬁnal
data set of feed samples (n = 654)
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Table 7 shows the mean and 95th concentration of the different feed samples. Most of the samples
referred to unprocessed samples (n = 581), mainly grain cereals but also few samples of diverse type
of grass. Samples of ‘Compound feed’ were also available divided by the type of animal to be fed;
overall, a very limited number of samples was available for each animal. The highest number of
samples were reported for barley grains (n = 222) and wheat grains (n = 201), with the highest levels
reported for rye grains (n = 21, LB–UB = 175–191 lg/kg).
Table 6: Average contribution of the different EAs to the total concentration in unprocessed and
processed feed samples with all the 12 EAs reported and at least one quantiﬁed
n = 302 n = 43 n = 259
Feed samples Processed feeds Unprocessed feeds
Ergometrine 5.4 5.6 5.4
Ergosine(a) 17.3 18.5 17.1
Ergocornine(a) 6.8 9.2 6.4
Ergotamine(a) 21.3 20.2 21.5
Ergocristine(a) 13.4 11.0 13.8
Ergometrinine 7.8 4.1 8.5
Ergosinine 5.3 4.5 5.4
Ergocorninine 3.6 4.9 3.3
Ergotaminine 4.5 4.5 4.5
Ergocristinine 4.4 5.7 4.2
Ergocryptine 5.7 6.6 5.5
Ergocryptinine 4.4 5.2 4.2
-ine (R)-epimers 69.1 71.1 69.7
-inine (S)-epimers 30.9 28.9 30.1
Four selected ergots(a) 58.8 58.9 58.8
(a): Four ergot alkaloids, ergotamine, ergocristine, ergosine and ergocornine, indicated in the 2012 EFSA opinion as the most
abundant among the Claviceps purpurea EAs (EFSA CONTAM Panel, 2012).
Table 7: Mean and 95th percentile concentration (lg/kg) of ergot alkaloids in different feed samples
Concentration (lg/kg)
Mean 95th percentile(a)Feed level 1 Feed level 2 Feed level 3 N %LC
(b)
LB MB UB LB MB UB
Cereal grains,
their products
and by-products
Barley Barley 222 70 15 30 44 71 97 124
Triticale Triticale 13 38 33 38 44 – – –
Wheat Wheat 201 43 92 99 106 389 389 392
Maize Maize 4 100 0 18 35 – – –
Oats Oats 89 54 38 54 71 166 169 183
Rye Rye 21 57 175 183 191 – – –
Spelt Spelt 2 0 60 60 60 – – –
Forages and
roughage, and
products derived
thereof
Grass, ﬁeld dried,
(hay)
Grass, ﬁeld dried, (hay) 20 50 34 47 60 – – –
Grass, herbs, legume
plants, (green forage)
9 0 63 63 63 – – –
Compound feed Complete feed Complete feed
unspeciﬁed
1 100 0 60 120 – – –
Calves (pre-ruminant) 1 0 6 16 26 – – –
Fattening sheep 7 43 24 34 43 – – –
Fattening goats 7 57 5 16 26 – – –
Poultry (starter diets) 2 0 15 24 33 – – –
Fattening chickens
(broilers)
4 75 41 50 59 – – –
Dietary exposure to ergot alkaloids
www.efsa.europa.eu/efsajournal 23 EFSA Journal 2017;15(7):4902
Looking at the samples of ‘Grain as crops’ reported in the previous section (Table 5), higher EA levels
were reported for rye, barley, wheat, oat and triticale grains as compared to the same grains reported as
feed. To cover worst-case situations and assuming that the samples of ‘Grain as crops’ could end up
entering in the feed chain, the 1,235 samples of ‘Grain as crops’ were combined with the feed samples.
Table 8 shows the summary statistics for the available number of feed samples once ‘Grain as crops’ and
feed samples were combined; the mean and 95th percentile levels shown in this table were used to
estimate animal exposure to EAs. In the merged data set, the highest mean EA levels were reported for
rye grains (LB–UB = 3,019–3,066 lg/kg, n = 192), followed by triticale and wheat grains with LB–
UB = 284–309 lg/kg (n = 115) and LB–UB = 240–265 lg/kg (n = 760), respectively.
Concentration (lg/kg)
Mean 95th percentile(a)Feed level 1 Feed level 2 Feed level 3 N %LC
(b)
LB MB UB LB MB UB
Laying hens 9 89 7 17 28 – – –
Fattening turkeys 3 100 0 12 24 – – –
Fattening ducks 1 100 0 12 24 – – –
Pet food, birds 4 0 60 60 60 – – –
Fattening cattle 3 0 123 127 131 – – –
Dairy cows 1 0 60 60 60 – – –
Piglets (weaning diets) 3 0 8 18 28 – – –
Growing/Fattening pigs 8 0 46 48 51 – – –
Breeding pigs 1 0 60 60 60 – – –
Lambs (weaning diets) 3 33 39 46 52 – – –
Complementary feed
(incomplete diet)
Complementary feed,
unspeciﬁed
1 0 60 60 60 – – –
Fattening sheep 3 33 13 22 31 – – –
Fattening goats 1 100 0 12 24 – – –
Fattening chickens
(broilers)
3 100 0 12 24 – – –
Pet food, birds 1 0 60 60 60 – – –
Dairy cows 6 17 50 53 56 – – –
N: number of samples; %LC: percentage of left-censored samples; LB: lower bound; MB: middle bound; UB: upper bound.
(a): Estimation of 95th percentile is not reliable when less than 60 observations are available.
(b): A sample was considered as left-censored when not a single EA was quantiﬁed.
Table 8: Mean and 95th percentile concentration (lg/kg) of ergot alkaloids in the data set as a result of combining
feed samples and those initially reported as ‘Grains as crops’ (see Table 5)
Concentration (lg/kg)
Mean 95th percentile(a)Feed level 1 Feed level 2 Feed level 3 N %LC
(b)
LB MB UB LB MB UB
Cereal grains,
their products
and by-products
Barley Barley(c) 395 57 59 86 113 309 310 324
Triticale Triticale(c) 115 27 284 296 309 1,603 1,603 1,603
Wheat Wheat(c) 760 38 240 253 265 499 513 522
Maize Maize 4 100 0 18 35 – – –
Oats Oats(c) 122 58 45 76 108 204 244 284
Rye Rye(c) 192 38 3,019 3,042 3,066 8,157 8,157 8,157
Spelt Spelt 2 0 60 60 60 – – –
Forages and
roughage, and
products derived
thereof
Grass, ﬁeld
dried, (Hay)
Grass, ﬁeld dried, (Hay) 20 50 34 47 60 – – –
Grass, herbs, legume plants,
(green forage)
9 0 63 63 63 – – –
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3.1.4. Data on ergot sclerotia
Two data providers submitted information on the content of ergot sclerotia in samples codiﬁed as
‘Grain as crops’, samples of unprocessed grains of unknown end-use. In addition, the United Kingdom
provided details to EFSA of a study on monitoring the presence of ergot alkaloids in cereals and the
potential relationship between sclerotia content and levels of ergot alkaloids.11 In this particular study,
197 samples of different grains were analysed for the 12 EAs, 12 of these samples being analysed
both before and after undergoing a cleaning process to remove visible sclerotia.
In relation to the data submitted, the ﬁrst data set (from the Croatian Food Agency) referred to 20
samples of rye grains that were also analysed for the presence of the 12 EAs. Nine samples where
ergot sclerotia were identiﬁed underwent manual cleaning and the concentration of EAs was
subsequently analysed and compared to that initially quantiﬁed.
The second data set (from Arvalis – Institut du vegetal) contained 2,526 results on ergot sclerotia in
different crops, in 74% of the cases with no sclerotia identiﬁed (1,878 samples). A total of 618 samples
were also analysed for their content on the 12 EAs (275 on wheat, 127 on barley, 102 on triticale, 100 on
rye and 14 on oat). In most of the cases, the samples were analysed for their EA content following
sclerotia identiﬁcation; only 41 samples with no identiﬁed sclerotia were also analysed for EAs.
In both data sets, ergot sclerotia were identiﬁed by visual inspection and the amounts reported
after gravimetric analysis.
Table 9 shows the samples from the two data sets where EA content was also analysed (n = 638).
The highest amounts of sclerotia were observed for rye grains (mean = 2.7 g/kg, 95th
percentile = 7.3 g/kg).
Concentration (lg/kg)
Mean 95th percentile(a)Feed level 1 Feed level 2 Feed level 3 N %LC
(b)
LB MB UB LB MB UB
Compound feed Complete feed Complete feed unspeciﬁed 1 100 0 60 120 – – –
Calves (pre-ruminant) 1 0 6 16 26 – – –
Fattening sheep 7 43 24 34 43 – – –
Fattening goats 7 57 5 16 26 – – –
Poultry (starter diets) 2 0 15 24 33 – – –
Fattening chickens (broilers) 4 75 41 50 59 – – –
Laying hens 9 89 7 17 28 – – –
Fattening turkeys 3 100 0 12 24 – – –
Fattening ducks 1 100 0 12 24 – – –
Pet food, birds 4 0 60 60 60 – – –
Fattening cattle 3 0 123 127 131 – – –
Dairy cows 1 0 60 60 60 – – –
Piglets (weaning diets) 3 0 8 18 28 – – –
Growing/Fattening pigs 8 0 46 48 51 – – –
Breeding pigs 1 0 60 60 60 – – –
Lambs (weaning diets) 3 33 39 46 52 – – –
Complementary
feed (incomplete
diet)
Complementary feed,
unspeciﬁed
1 0 60 60 60 – – –
Fattening sheep 3 33 13 22 31 – – –
Fattening goats 1 100 0 12 24 – – –
Fattening chickens (broilers) 3 100 0 12 24 – – –
Pet food, birds 1 0 60 60 60 – – –
Dairy cows 6 17 50 53 56 – – –
N: number of samples; %LC: percentage of left-censored samples; LB: lower bound; MB: middle bound; UB: upper bound.
(a): Estimation of 95th percentile is not reliable when less than 60 observations are available.
(b): A sample was considered as left-censored when not a single EA was quantiﬁed.
(c): Occurrence values resulting from combining grains reported as feed and those reported as ‘Grains as crops’.
11 https://www.food.gov.uk/science/research/chemical-safety-research/env-cont/fs516009
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3.2. Human dietary exposure assessment to ergot alkaloids
Based on the outcome of the EFSA 2012 CONTAM opinion, both chronic and acute dietary exposure
to EAs were assessed (EFSA CONTAM Panel, 2012).
Before linking consumption and occurrence data, some adjustments were carried out on both data
sets in order to obtain the most accurate exposure estimates possible. First, consumption data were
grouped at the same levels as described for the occurrence data (see Table 4, ‘Food group’).
Conversion factors were used in the consumption data when needed to match the occurrence values
reported in dry samples with their respective liquid consumption amounts. This occurs for some of the
eating occasions of ‘Cereal-based food for infants and young children’ reported as consumed that were
divided by a factor of either 7 or 4 depending on whether they refer to ‘Simple cereals which are or
have to be reconstituted with milk or other appropriate nutritious liquids’ or to ‘Cereals with an added
high protein food which are or have to be reconstituted with water or other protein-free liquid’,
respectively. Since no speciﬁc occurrence data were available to cover eating occasions reported as
‘Mixed breakfast cereals’ and ‘Breakfast cereals unspeciﬁed’, these eating occasions were linked to the
food group ‘Cereal ﬂakes, unspeciﬁed’. Likewise, as only few samples of porridge (n = 7, see
Appendix D) were available and this is a food commodity with relatively high number of eating
occasions, the occurrence values for the different ﬂakes (oat, wheat and rye) were assigned to the
consumption of porridge. Eating occasions for porridge reported as liquid/consumed were divided by a
factor of 5 before being linked to the occurrence data of the cereal ﬂakes.
3.2.1. Chronic dietary exposure
Dietary exposure to EAs was estimated in 35 dietary surveys from 19 different European countries.
Table 10 shows summary statistics for mean and 95th percentile chronic dietary exposure to EAs
across different age classes. Detailed mean and 95th percentile dietary exposure estimates calculated
for each of the 35 dietary surveys are presented in Appendix E.
Table 9: Amounts of ergot sclerotia (g/kg) reported in different grains (reported as ‘Grains as
crops’) where ergot alkaloid content was also measured
Amount of ergot sclerotia (g/kg)
N
Mean 95th percentile Range(a) (min–max)
Barley grain 127 0.06 0.24 0.002–1.15
Oat grain 14 0.03 – 0.001–0.15
Rye grain 120 2.68 7.30 0.003–105.6
Triticale grain 102 0.12 0.52 0.002–1.90
Wheat grain 275 0.09 0.26 0.003–2.71
(a): Among those quantiﬁed.
Table 10: Summary statistics of chronic dietary exposure to EAs (ng/kg bw per day) across
European dietary surveys and different age classes
Mean dietary exposure (lg/kg bw per day)
Lower bound Upper boundAge class
(a)
N
Min Median Max Min Median Max
Infants 6 0.01 0.02 0.08 0.03 0.15 0.34
Toddlers 10 0.03 0.06 0.12 0.18 0.25 0.47
Other children 18 0.02 0.05 0.17 0.14 0.20 0.46
Adolescents 17 0.01 0.03 0.15 0.07 0.12 0.29
Adults 17 0.01 0.02 0.05 0.06 0.09 0.18
Elderly 14 0.01 0.02 0.05 0.05 0.09 0.14
Very elderly 12 0.01 0.02 0.06 0.05 0.09 0.16
Dietary exposure to ergot alkaloids
www.efsa.europa.eu/efsajournal 26 EFSA Journal 2017;15(7):4902
Overall, chronic dietary exposure to EAs in the youngest age classes (‘Infants’, ‘Toddlers’, and ‘Other
children’) were 2–3 times higher than those estimated for the adult population (‘Adults’, ‘Elderly’, and
‘Very elderly’). UB estimations were on average fourfold higher than LB estimations.
Mean dietary exposure was highest in ‘Toddlers’ and ‘Other children’ with maximum UB estimates of
0.47 and 0.46 lg/kg bw per day, respectively. Considering both the LB and the UB scenarios, the
estimates for mean exposure ranged from 0.01 lg/kg bw per day (minimum LB) in diverse age classes
to 0.47 lg/kg bw per day (maximum UB) for ‘Toddlers’.
The 95th percentile dietary exposure was highest in ‘Toddlers’ with a maximum UB estimate of
0.86 lg/kg bw per day. Considering both the LB and the UB scenarios, the estimates for 95th
percentile dietary exposure ranged from 0.02 lg/kg bw per day (minimum LB) in diverse age classes
to 0.86 lg/kg bw per day (maximum UB) for ‘Toddlers’.
Chronic dietary exposure in the two dietary surveys covering ‘Pregnant women’ and ‘Lactating
women’ were within the range of exposure estimates in the adult population; these exposure
estimates are shown in Appendix E.
It should be mentioned that few dietary surveys, including those with the two highest estimates
(0.79 and 0.86 lg/kg bw per day, 95th percentile, UB), reported all or part of the consumption data
disaggregated into minimally processed commodities (e.g. rye and wheat milling products). As seen in
Table 4, the available occurrence data for minimally processed commodities (e.g. ‘Rye milling products’,
LB = 198 lg/kg) were rather high as compared to the derived processed food. The disaggregated
consumption data in these dietary surveys do not specify the original consumed processed commodity
(e.g. cake, bread, etc.), which prevents the application of any factor to return to the processed
commodities. Likewise, at the level of occurrence data, the lack of conclusive and precise data on the
fate of EAs during baking makes it impossible to apply any retention factor for the EAs. Therefore, the
dietary exposure where the consumption data are totally disaggregated to RAC was most likely
overestimated as it was assumed that the concentration of EAs reported for the RAC is not affected by
processing.
In any case, in several of the dietary surveys among those with high exposure estimates (e.g.
0.76 lg/kg bw per day for ‘Infants’ and 0.67 lg/kg bw per day for ‘Other children’, 95th percentile,
UB) consumption data were not reported disaggregated to minimally processed commodities. For the
particular case of the dietary survey on ‘Infants’, the main contributors to the exposure (MB scenario)
were ‘Rye bread and rolls’ (36%) and ‘Cereal ﬂakes’ (30%), going up to 61% for ‘Rye bread and rolls’
when looking at the LB estimations. It is important to note the large variation associated with certain
food contributors when considering LB–UB exposure estimations due to the high number of left-
censored data and the relatively high LOQs reported for certain samples (see Appendix E for food
contributors).
Overall, among the processed foods, the main contributors to the dietary exposure to EAs were
different types of bread and rolls, in particular those containing or made exclusively of rye. In some
countries such as Austria, the contribution of ‘Mixed wheat and rye bread and rolls’ to the exposure to
EAs represented up to 84% (MB) of the total. The consumption of rye-derived processed foods was
also important in Nordic countries, where the contribution of ‘Rye bread and rolls’ went up to 61% of
95th percentile dietary exposure(b) (lg/kg bw per day)
Lower bound Upper boundAge class
(a)
N
Min Median Max Min Median Max
Infants 5 0.05 –(c) 0.19 0.29 –(c) 0.76
Toddlers 7 0.07 0.18 0.30 0.38 0.59 0.86
Other children 18 0.05 0.12 0.39 0.29 0.42 0.79
Adolescents 17 0.03 0.07 0.33 0.14 0.27 0.56
Adults 17 0.02 0.04 0.12 0.12 0.18 0.36
Elderly 14 0.02 0.04 0.10 0.11 0.17 0.28
Very elderly 9 0.02 0.03 0.09 0.12 0.15 0.26
bw: body weight; Max: maximum; Min: minimum; n: number of surveys.
(a): Section 2.1.2 describes the age range within each age class.
(b): The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be statistically
robust (EFSA. 2011b). Those estimates were not included in this table.
(c): Minimum number of six dietary surveys are required to estimate a statistically robust median (EFSA, 2011b).
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the total and up to 65% for ‘Mixed wheat and rye bread and rolls’ in some dietary surveys. ‘Wheat
bread and rolls’ also played an important role as contributor to the dietary exposure to EAs (up to
80% of the total, MB), usually in dietary surveys from Mediterranean countries. However, in general,
these countries were not among those with the highest exposure estimates. Other food commodities
that contributed to the exposure to EAs were ‘Breakfast cereals’ in general, and ‘Cereal ﬂakes’ in
particular, with contributions up to 43% at the MB.
Detailed information on the different food contributors by age class and dietary survey is shown in
Appendix E.
3.2.2. Acute dietary exposure
Acute dietary exposure to EAs was estimated using a probabilistic approach in 41 dietary surveys
from 23 different European countries.
Considering that the ﬁnal EA content in the samples results from the sum of up to 12 individual
compounds and the vast amount of left-censored data (only 11% of the analytical results were
quantiﬁed), to estimate acute dietary exposure the MB scenario in the individual occurrence data was
used as the UB scenario would represent an overly conservative exposure scenario.
Table 11 shows the range of average and 95th percentile acute exposures across different age
classes and dietary surveys considering the whole population. Information is also given on the
percentage of subjects above the ARfD in all the different iterations (n = 1,000); an ARfD = 1 lg/kg
bw per day was derived in the 2012 EFSA CONTAM opinion (EFSA CONTAM Panel, 2012).
Average acute exposure went from a minimum of 0.02 lg/kg bw per day estimated in ‘Infants’ up to
a maximum of 0.32 lg/kg bw per day estimated in ‘Other children’. Regarding the 95th percentile acute
dietary exposure, the highest estimates were for a dietary survey within the age class ‘Other children’
(0.98 lg/kg bw per day). Overall, the young population (‘Infants’, ‘Toddlers’, ‘Other children’) showed
higher acute exposure to EAs than the other age classes. Acute dietary exposure in the two dietary
surveys covering ‘Pregnant women’ and ‘Lactating women’ were within the range of exposure estimates
in the adult population. Detailed acute exposure estimates for each dietary survey across age classes
with their corresponding conﬁdence intervals (2.5th and 97.5th percentiles) are described in Appendix F.
Table 11: Range of acute exposure assessment (average and 95th percentile, MB scenario)(a) to
ergot alkaloids across European dietary surveys, and percentage of subjects above the
acute reference dose(b)
Rangeof average acute exposure
(lg/kg bw per day)Age class
(c)
Number dietary surveys Minimum Median Maximum
Infants 6 0.02 (0.01–0.04) 0.08 0.21 (0.20–0.21)
Toddlers 11 0.11 (0.11–0.11) 0.15 0.30 (0.29–0.30)
Other children 20 0.08 (0.08–0.08) 0.13 0.32 (0.30–0.33)
Adolescents 20 0.04 (0.04–0.05) 0.07 0.23 (0.21–0.24)
Adults 22 0.03 (0.03–0.03) 0.06 0.17 (0.16–0.17)
Elderly 16 0.03 (0.03–0.03) 0.05 0.13 (0.11–0.14)
Very elderly 14 0.03 (0.03–0.04) 0.05 0.12 (0.10–0.15)
Rangeof 95th percentile acute exposure
(lg/kg bw per day)
Number dietary surveys Minimum Median Maximum
Infants 5 0.26 (0.25–0.27) –(d) 0.65 (0.62–0.68)
Toddlers 10 0.35 (0.31–0.38) 0.50 0.79 (0.76–0.83)
Other children 20 0.27 (0.25–0.30) 0.40 0.98 (0.90–1.06)
Adolescents 20 0.13 (0.11–0.16) 0.26 0.77 (0.67–0.89)
Adults 22 0.10 (0.10–0.11) 0.21 0.49 (0.46–0.53)
Elderly 16 0.10 (0.09–0.11) 0.16 0.37 (0.29–0.48)
Very elderly 14 0.10 (0.09–0.11) 0.16 0.39 (0.27–0.51)
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Looking at the acute exposure (consumers only) from the different food commodities, in very few
occasions the consumption of only one food resulted in mean estimates close or above 1 lg/kg bw per
day (Appendix F). This referred to population groups with very low number of consumers, and above
all, to the consumption of certain grains (e.g. rye grain) or minimally processed commodities (e.g. rye
milling products). As explained above, the dietary exposure derived from the reported consumption of
minimally processed commodities is most probably overestimated as the data in most of the cases do
not refer to consumption of these commodities but to disaggregated data from consumed processed
commodities.
For cereal-based processed commodities, the most relevant foods involved in the acute exposure to
EAs were the same as those identiﬁed for the chronic dietary exposure. They mainly refer to ‘Mixed
wheat and rye bread and rolls’ and ‘Rye bread and rolls’. For high consumers, the single consumption
of ‘Mixed wheat and rye bread and rolls’ can lead to acute exposure estimates up to 0.74 (95%
CI = 0.59–0.93) lg/kg bw per day while for ‘Rye bread and rolls’ the exposure can reach values up to
0.64 (95% CI = 0.60–0.69) lg/kg bw per day. Detailed information on the exposure levels that can be
reached following the consumption of diverse single commodities is given in Appendix F.
As can be seen, no big differences were observed between estimates of chronic and acute
exposure (MB scenario) indicating that the main contributors to the exposure are foods consumed on a
regular basis within particular populations, together with a relatively symmetric distribution of their
occurrence values.
3.3. Animal exposure
Although in animal nutrition, compound feeds (complementary or complete feeds) represent a very
large proportion of the feed consumed by the farmed animals, the available data on the occurrence of
EAs in these commodities are scarce (low number of samples available for each target species/
category) and do not allow a reliable exposure estimate to be made. Therefore, only the occurrence
data on grain cereals and on forages and roughage reported in Table 8 were used to calculate animal
exposure.
Two scenarios were considered in the calculation of animal exposure: a mean occurrence scenario,
in which the mean LB and UB values for each feedingstuff were used to estimate EA dietary
concentrations; and a high occurrence scenario, in which the high (P90 or P95) LB and UB values were
used. The calculated mean and high concentrations of dietary EAs (reported in Appendix B,
Sections B.2.1–B.2.5) were combined with the estimated feed intake (also described in Appendix B) to
obtain the estimated exposure of the different animal species and categories in the two scenarios. The
detailed results, summarised below, are tabulated in the Appendix G.
Dietary exposure to EAs in dairy cows varied between 1.41 (LB) and 1.75 (UB) lg/kg bw per day
using the mean occurrence scenario, and between 4.53 and 4.58 lg/kg bw per day in the high exposure
scenario. The corresponding exposure of beef cattle varies between 0.31 and 2.05 and between 1.43 and
6.30 lg/kg bw per day in the two exposure scenarios. Sheep (1.14–1.38 and 3.74–3.78 lg/kg bw per
day), milking goats (2.43–4.35 and 11.28–11.91 lg/kg bw per day) and fattening goats (0.82–1.51 and
3.80–4.04 lg/kg bw per day) showed a similar exposure.
Percentage of subjects above the acute reference dose (ARfD)(b)
Number dietary surveys Minimum Maximum
Infants 6 0.1 10
Toddlers 11 1 18
Other children 20 0.1 13
Adolescents 20 < 0.01 11
Adults 22 < 0.01 1
Elderly 16 0 1
Very elderly 14 0 1
(a): With their corresponding conﬁdence intervals (2.5th and 97.5th percentiles).
(b): Range of percentage of subjects above the acute reference dose (ARfD) after 1,000 iterations in each of the dietary surveys
and age classes. ARfD = 1 lg/kg bw per day as derived in the 2012 EFSA CONTAM opinion (EFSA CONTAM Panel, 2012).
(c): Section 2.1.2 describes the age range within each age class.
(d): Minimum number of six dietary surveys are required to estimate a statistically robust median (EFSA, 2011b).
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Pigs showed comparable levels of exposure for the three categories at both mean and high
exposure scenarios: piglets 6.82–8.07 and 16.38–16.61 lg/kg bw per day, fattening pigs 4.68–5.48
and 12.02–12.16 lg/kg bw per day, and lactating sows 4.92–5.58 and 12.31–12.43 lg/kg bw per day.
The same levels of exposure can be observed in poultry species, with values for broilers of
5.78–7.16 and 11.75–12.68 lg/kg bw per day, for laying hens 4.46–5.65 and 8.89–9.74 lg/kg bw per
day, for turkeys for fattening 3.50–4.50 and 10.21–10.38 lg/kg bw per day, and for ducks for
fattening 6.53–7.56 and 16.19–16.38 lg/kg bw per day.
Rabbit showed exposure levels of 1.74–2.98 and 7.04–8.19 lg/kg bw per day.
Fish (salmonids) showed exposure levels of 0.65–0.72 and 1.30–1.32 lg/kg bw per day.
Lower exposure levels were observed in companion animals, being for dogs 0.53–1.11 and
1.50–1.96 lg/kg bw per day, for cats 0.55–1.16 and 1.56–2.04 lg/kg bw per day, and for horses
0.88–1.28 and 3.38–3.59 lg/kg bw per day, respectively, in the two exposure scenarios.
The exposure levels of the ﬁve relevant target species/categories increased considerably when rye
was included in the diets. The exposure of pigs for fattening ranged between 25.71 (LB mean
scenario) to 67.26 (UB high scenario) lg/kg bw per day, and for lactating sows from 17.91 (LB mean
scenario) to 46.61 (UB high scenario) lg/kg bw per day. Exposure of laying hens was calculated
between 19.95 (LB mean scenario) and 50.86 (UB high scenario) lg/kg bw per day. The inclusion of
rye in diets for ruminants had a smaller impact on the exposure level ranging from 2.83 (LB mean
scenario) to 12.85 (UB high scenario) lg/kg bw per day.
3.4. Ergot sclerotia and concentration of ergot alkaloids
Following the Terms of reference (Section 1.1), a potential relationship between the content of
ergot sclerotia and the levels of EAs was assessed. Likewise, the efﬁciency of the removal of ergot
sclerotia on the presence of EAs was also evaluated, considering the different analytical data and
information received. LB estimations were used when referring to the EA content; this could imply
some underestimation of the EA contents as around 60% of the analytical data were left-censored
and, consequently, a bias in the evaluation of the relationship between the content of ergot sclerotia
and the levels of EAs.
As mentioned in Section 3.1.3, two data sets containing samples with data on both ergot sclerotia
and EAs were submitted to EFSA, one data set submitted by the Croatian Food Agency with 20
samples of rye grains, and one submitted by Arvalis – Institut du vegetal with 2,526 samples on
different grains, of which 618 were also analysed for the EA content.
A correlation analysis was carried out to quantify the strength of a linear relationship between the
content of sclerotia and the levels of ergot alkaloids for samples of barley, triticale, rye and wheat. A
Pearson product-moment correlation coefﬁcient or Pearson’s correlation was used with a signiﬁcance
level (a) of 0.05%. Before evaluating the potential correlation between ergot sclerotia and EA content,
the 20 samples of rye grains were merged with the other data set, containing 618 samples (among
them 100 samples of rye) in which EAs were analysed because of the presence of sclerotia.
The graphs in Figure 13 show the relationship between the content of sclerotia and the levels of
ergot alkaloids for the samples of wheat, triticale, barley and rye; the Pearson’s correlation coefﬁcients
for each of the crops evaluated are shown in Table 12. It can be seen that for all crops there was a
strong and signiﬁcant (p-value < 0.0001) linear relationship between the content of sclerotia and the
levels of EAs analysed; Pearson correlation coefﬁcients ranged between 0.806 for rye grains and 0.972
for triticale grains. Similar strong linear correlation has been reported in wheat samples (Tittlemier
et al., 2015), although other studies (in rye and triticale) indicated low association between EA content
and sclerotia (Mulder et al., 2012). However, the observed correlation between EA content and
sclerotia levels in this study it is not sufﬁcient to be used to predict EA content based on sclerotia or
vice versa (correlation but not causation).
There were 87 samples where ergot sclerotia were visually detected and then quantiﬁed, some of
them at relatively high concentrations (range 1.1–180 mg/kg), whereas no EAs could be quantiﬁed.
This conﬁrms reports in the literature where it was hypothesised that there may have been a potential
contamination with Claviceps strains that do not produce EAs (Battilani et al., 2009, Wegulo and
Carison, 2011; Mulder et al., 2012).
Concerning the presence of EAs in the absence of sclerotia, in the ﬁrst data set from Croatia,
among the 11 samples of rye grains with no sclerotia identiﬁed after visual inspection, there were ﬁve
occasions (46%) where at least one EA was quantiﬁed (total EAs ranging from 22 to 171 lg/kg, LB
scenario). In the other data set, among the 41 samples with no visual detection of sclerotia, six
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samples (15%) were found to contain EAs (range 10–23 lg/kg). This situation has been reported in
the past in different studies and it could be explained by the presence of very small particles resulting
from the breakage of the sclerotia that remained unnoticed (Wegulo et al., 2011; Mulder et al., 2012).
It can be concluded that, in general, the presence of ergot sclerotia is a good indicator for the
presence of EAs in grain samples, with only 14% of samples with sclerotia identiﬁed showing no
quantiﬁed levels of EAs (‘false positives’). However, the absence of sclerotia does not exclude the
presence of EAs, since there were several samples with no sclerotia detected that showed measurable
levels of EAs (‘false negatives’).
The efﬁciency of the removal of ergot sclerotia on the total amount of EAs was also evaluated. A
couple of studies have been recently published covering this issue. In a project funded by the UK Food
Standards Agency and carried out by Campden BRI, it was reported that, although based on a limited
number of samples, the applied cleaning processes signiﬁcantly reduced the levels of EAs (Byrd et al.,
2014). As an example, an initial EA content of 20,457 lg/kg in one sample of oats was reduced to
1 lg/kg following sclerotia removal. This particular study covered diverse samples of barley (n = 11),
rye (n = 6), oat (n = 1) and wheat (n = 1), and different cleaning processes: from manual removal
following visual examination (wheat and barley) to an optical sorting process (rye and oat). Similarly,
another study on different feed samples reported that manual removal of sclerotia resulted in an
average reduction of the EA content of 70%, with the lowest efﬁciency in samples of triticale (52.3%
EA content remaining) (Mulder et al., 2012).
Table 12: Correlation analysis between content of sclerotia and levels of ergot alkaloids in different
crops
Number of samples Pearson’s coefﬁcient p-value
Barley grains 127 0.927 < 0.0001
Oats grains 14 0.948 < 0.0001
Rye grains 120 0.806 < 0.0001
Triticale 102 0.972 < 0.0001
Wheat grains 275 0.969 < 0.0001
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Figure 13: Relationship between the amount of ergot sclerotia and ergot alkaloids in samples of (A)
wheat (n = 275), (B) barley (n = 127), (C) rye (n = 120) and (D) Triticale (n = 102)
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The data available to EFSA only pertained to nine samples of rye grain analysed for EAs before and
after undergoing a cleaning process. Determination of ergot sclerotia was carried out following
macroscopic and microscopic identiﬁcation of ergot sclerotia and fragments, weighing the amount of
identiﬁed sclerotia and fragments with a particle size > 0.5 mm.12 Surprisingly, no reduction was
observed in the EA levels following the cleaning process (Figure 14). The analysis of the removed
ergot sclerotia showed that their content in EAs was very low and could not explain the EA levels
quantiﬁed in these rye grains. Although some studies have postulated a possible transfer of EAs from
the sclerotia into the kernels during plant growth (Wolff and Richter, 1989), other researchers could
not conclude on this (Mainka et al., 2007).
4. Uncertainties
A qualitative evaluation of the inherent uncertainties in the assessment of the dietary exposure to
EAs was performed following the guidance of the Opinion of the Scientiﬁc Committee related to
Uncertainties in Dietary Exposure Assessment (EFSA, 2007).
Concerning occurrence data, most of the data submitted by Member States (MSs) originates from
targeted monitoring programmes, which might have led to overestimation of EA levels and as a
consequence to overestimation of the dietary exposure. There is uncertainty related to the
representativity of the food and feed samples across Europe, in particular for feed since data came
primarily from a few countries. The large proportion of left-censored data introduces uncertainty to the
overall dietary exposure estimates. This is particularly relevant for EAs as the ﬁnal content in the
samples results from the sum of up to 12 individual compounds, and even more in food samples
where only 11% of the analytical results were quantiﬁed. While the LB values tend to underestimate
the dietary exposure to EAs, UB values tend to overestimate it. The limited number of available
samples for particular food and feed subgroups adds uncertainty to the representativity of the mean
concentration values used to estimate exposure. Although many relevant processed foods were
available, it cannot be discarded that food commodities that may contain EAs are not represented in
the available data set leading, therefore, to an underestimation of the dietary exposure to EAs.
Regarding feed, the use of samples reported as ‘Grain as crops’ as feed may imply overestimation
of the animal exposure as these samples were reported with relatively high EA content and their use
as feed is not conﬁrmed. Likewise, the reduced number of samples of compound feeds prevents their
use in the exposure estimations which could imply an underestimation of the animal exposure to EAs.
Uncertainties and limitations related to the use of the EFSA Comprehensive Food Consumption
Database have already been described elsewhere (EFSA, 2011b) and are not further detailed; only
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Figure 14: Levels of ergot alkaloids reported for nine samples of rye grain before and after manual
removal of ergot sclerotia
12 International Association of Feedingstuff Analysis, Section Feedingstuff Microscopy. Method for the Determination of Ergot
(Claviceps purpurea Tul.) in Animal Feedingstuff, AG-Method A4.
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those with a particular impact on the dietary exposure to EAs are mentioned here. The main
uncertainty refers to eating occasions reported as raw agricultural/minimally processed commodities
derived from consumption data on processed foods that were disaggregated. The disaggregated
consumption data in these dietary surveys do not specify the original consumed processed commodity
(e.g. cake, bread, etc.) which makes it impossible to apply any factor to return to the processed
commodities. These consumption data were linked to EA levels in raw agricultural/minimally processed
commodities with no factors applied to cover the possible elimination of EAs during processing. As a
result, the dietary exposure estimations obtained for these dietary surveys are likely overestimated.
Table 13 shows a summary of the uncertainty evaluation indicating an estimate of whether the
respective source of uncertainty might have led to an over- or underestimation of the exposure.
Both chronic and acute estimates were particularly affected by the high proportion of left-censored
data, particularly relevant for EAs as the ﬁnal content in the samples results from the sum of up to 12
individual compounds. Overall, lower bound estimations of chronic exposure to EAs most likely
underestimated the exposure levels of the European population, while middle and, above all, upper
bound exposure are most likely overestimated. Similarly, acute exposure estimates to EAs are likely
overestimated by using the middle bound scenario.
5. Conclusions
The most recent available data on EAs (2011–2016) in food (4,528 samples) and feed (654
samples) as well as 1,234 samples initially codiﬁed as ‘Grain as crops’ were used to estimate human
and animal dietary exposure. In 97% of the samples, the analysis covered the 12 main C. purpurea
EAs: ergometrine, ergosine, ergocornine, ergotamine, ergocristine, ergocryptine (a- and b-isomers)
and the corresponding –inine (S)-epimers. In addition to the data on EAs, for 2,546 samples,
information on the content of ergot sclerotia was submitted by two different providers.
• In food, the highest levels of EAs were reported in rye and rye-containing commodities, in
particular in raw agricultural or minimally processed commodities (e.g. ‘Rye milling products,
198–239 lg/kg, LB–UB). Among processed food, the highest levels of EAs were found in
‘Mixed wheat and rye bread and rolls’ (33–82 lg/kg), ‘Rye bread and rolls’ (29–67 lg/kg) and
‘Rye ﬂakes’ (35–83 lg/kg), always for LB–UB scenarios.
• Mean dietary exposure was highest in ‘Toddlers’ and ‘Other children’ with maximum UB
estimates of 0.47 and 0.46 lg/kg bw per day, respectively. The 95th percentile dietary
exposure was highest in ‘Toddlers’ with a maximum UB estimate of 0.86 lg/kg bw per day.
Overall, chronic dietary exposure to EAs in the young population (‘Infants’, ‘Toddlers’, and
‘Other children’) was 2–3 times higher than that estimated for the adult population (‘Adults’,
‘Elderly’, and ‘Very elderly’). UB estimations were in average fourfold higher than LB
estimations.
• Among processed foods and within the dietary surveys with the highest exposure estimates,
the main contributors to chronic dietary exposure were different types of bread and rolls, in
particular those containing or made exclusively of rye.
Table 13: Summary of the qualitative evaluation of the impact of uncertainties on the dietary
exposure to EAs
Sources of uncertainty Direction(a)
Measurement uncertainty of analytical results associated to the methods of analysis +/
Large proportion of left-censored data in the ﬁnal data set +/
Using the substitution method at the lower-bound (LB) scenario 
Using the substitution method at the lower–bound (MB) scenario +/
Using the substitution method at the upper–bound (UB) scenario +
Representativity of occurrence data to the whole of Europe +/
Reporting of consumption data on raw agricultural commodities derived from consumption of
processed foods
+
Lack of occurrence data on relevant food and feed commodities 
Use of samples reported as ‘Grain as crops’ for animal exposure +
(a): + = uncertainty with potential to cause overestimation of exposure;  = uncertainty with potential to cause underestimation
of exposure.
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• Average acute exposure ranged from 0.02 lg/kg bw per day estimated in ‘Infants’ to 0.32 lg/
kg bw per day estimated in ‘Other children’. For the 95th percentile acute dietary exposure, the
highest estimate was for a dietary survey within the age class ‘Other children’ (0.98 lg/kg bw
per day).
• For cereal-based processed commodities, the most relevant foods involved in the acute
exposure to EAs were ‘Mixed wheat and rye bread and rolls’ and ‘Rye bread and rolls’. In high
consumers, a single consumption of ‘Mixed wheat and rye bread and rolls’ can lead to acute
exposure estimates up to 0.74 (95% CI = 0.59–0.93) lg/kg bw per day and up to 0.64 (95%
CI = 0.60–0.69) lg/kg bw per day in the case of ‘Rye bread and rolls’.
• As compared to the 2012 EFSA opinion, a much higher number of food commodities was
available, in particular on processed foods. This probably led to higher chronic dietary
exposure estimates as compared to those in 2012, although also the overall EA content seems
to be slightly higher in the food samples used for the current assessment. Highest acute
dietary exposure estimates were similar to those reported in 2012.
• Animal dietary exposure varied according to the animal species. The exposure considering a
mean concentration scenario varied between 0.31–0.46 lg/kg bw per day in beef cattle and
6.82–8.07 lg/kg bw per day (LB–UB) in piglets. While considering a high concentration
scenario the exposure varied between 1.43–1.45 lg/kg bw per day and 16.38–16.61 lg/kg bw
per day (LB–UB) in the same species. When rye is included in the diets, the exposure of the
relevant species increases up to levels of 25.71–26.47 lg/kg bw per day in the mean
concentration scenario up to 67.19–67.26 lg/kg bw per day (LB–UB) in the high concentration
scenario in pigs for fattening, the species with the highest exposure level.
• In all crops assessed (barley, oats, rye, triticale and wheat grains) there was a strong and
statistically signiﬁcant (p-value < 0.0001) linear relationship between the content of sclerotia
and the levels of EAs analysed, with Pearson correlation coefﬁcients ranging between 0.806 for
rye grains and 0.972 for triticale grains.
• The presence of ergot sclerotia is a good indicator for the presence of EAs in grain samples,
with only 14% of samples with sclerotia identiﬁed showing no quantiﬁed levels of EAs (‘false
positives’). However, the absence of sclerotia does not exclude the presence of EAs, since
there were several samples with no sclerotia detected that showed measurable levels of EAs
(‘false negatives’).
• In the very few samples (n = 9) submitted to EFSA where it was possible to assess the
efﬁcacy of the removal of sclerotia on decreasing the levels of EAs, no reduction was observed
following a cleaning process. Further studies are needed to conﬁrm these results that do not
agree with ﬁndings previously reported in the literature.
6. Recommendations
• Collection of analytical data on EAs in relevant food and feed commodities should continue,
with special attention to processed foods.
• Simultaneous collection of data on the presence of ergot sclerotia and on the EA content in
different food and feed commodities should continue to help better understand the relationship
between these two variables.
• As the EA pattern seems to depend on many different factors (crop, epimerisation during
processing and/or analysis, etc.), it is recommended that monitoring should continue for at
least the EAs already listed in Commission Recommendation 2012/154/EU.
• Available analytical methods with the appropriate sensitivity should be used to reduce the
uncertainty associated with the different occurrence scenarios and, consequently, with dietary
exposure estimations.
References
AFRC (Agricultural and Food Research Council), 1993. Energy and Protein Requirements of Ruminants. An advisory
manual prepared by the AFRC Technical Committee on Responses to Nutrients. CAB International.
Battilani P, Costa LG, Dossena A, Gullino ML, Marchelli R, Galaverna G, Pietri A, Dall’Asta C, Giorni P, Spadaro D
and Gualla A, 2009. Scientiﬁc information on mycotoxins and natural plant toxicants. Scientiﬁc/Technical Report
submitted to EFSA, CFP/EFSA/CONTAM/2008/01.
Baumann U, Hunziker HR and Zimmerli B, 1985. Ergot alkaloids in Swiss cereal products. Mitteilungen aus dem
Gebiete der Lebensmitteluntersuchung und Hygiene, 76, 609–630.
Dietary exposure to ergot alkaloids
www.efsa.europa.eu/efsajournal 34 EFSA Journal 2017;15(7):4902
Byrd N, De Alwis J, Booth M and Jewell K, 2014. Monitoring the Presence of Ergot Alkaloids in Cereals and a Study
of the Possible Relationship between Occurrence of Sclerotia Content and Levels of Ergot alkaloids. Food
Standard Agency, Final report, Project number FS516009. Available online: https://www.food.gov.uk/sites/defa
ult/files/FS516009%20Final%20Ergot%20Alkaloid%20report%20%283%29.pdf
Carabano R and Piquer J, 1998. The digestive system of the rabbit. In: de Blas C, Wiseman J (eds.). The Nutrition
of the Rabbit. CABI Publishing, Oxon, UK, pp. 1–16.
Coufal-Majewski S, Stanford K, McAllister T, Blakley B, McKinnon J, Chaves AV and Wang Y, 2016. Impacts of
cereal Ergot in food animal production. Frontiers in Veterinary Science, 3, 15. https://doi.org/10.3389/fvets.
2016.00015
Crews C, 2015. Analysis of Ergot Alkaloids. Toxins, 7, 2024–2050. https://doi.org/10.3390/toxins7062024
Diana Di Mavungu JD, Larionova DA, Malysheva SV, Van Peteghem C and De Saeger S, 2011. Survey on ergot
alkaloids in cereals intended for human consumption and animal feeding. Scientiﬁc report submitted to EFSA.
Available online: http://www.efsa.europa.eu/en/supporting/pub/214e.htm
Diana Di Mavungu J, Malysheva SV, Sanders M, Larionova D, Robbens J, Dubruel P, Van Peteghem C and De
Saeger S, 2012. Development and validation of a new LC-MS/MS method for the simultaneous determination of
six major ergot alkaloids and their corresponding epimers. Application to some food and feed commodities.
Food Chemistry, 135, 292–303. https://doi.org/10.1016/j.foodchem.2012.04.098
EFSA (European Food Safety Authority), 2005. Scientiﬁc Opinion of the Scientiﬁc Panel on Contaminants in the Food
Chain on a request from the European Commission related to ergot as undesirable substance in animal feed. EFSA
Journal 2005;3(5):225, 1–27 pp. https://doi.org/10.2903/j.efsa.2005.225
EFSA (European Food Safety Authority), 2007. Opinion of the Scientiﬁc Committee related to Uncertainties in
Dietary Exposure Assessment. EFSA Journal 2007;5(1):438, 54 pp. https://doi.org/10.2903/j.efsa.2007.438
EFSA (European Food Safety Authority), 2009a. Guidance for the preparation of dossiers for sensory additives.
EFSA Journal 2012;10(1):2534, 26 pp. https://doi.org/10.2903/j.efsa.2012.2534
EFSA (European Food Safety Authority), 2010a. Standard sample description for food and feed. EFSA Journal
2010;8(1):1457, 54 pp. https://doi.org/10.2903/j.efsa.2010.1457
EFSA (European Food Safety Authority), 2010b. Management of left-censored data in dietary exposure assessment
of chemical substances. EFSA Journal 2010;8(3):1557, 96 pp. https://doi.org/10.2903/j.efsa.2010.1557
EFSA (European Food Safety Authority), 2011a. Evaluation of the FoodEx, the food classiﬁcation system applied to
the development of the EFSA Comprehensive European Food Consumption Database. EFSA Journal 2011;9
(3):1970, 27 pp. https://doi.org/10.2903/j.efsa.2011.1970
EFSA (European Food Safety Authority), 2011b. Use of the EFSA Comprehensive European Food Consumption
Database in Exposure Assessment. EFSA Journal 2011;9(3):2097, 34 pp. https://doi.org/10.2903/j.efsa.2011.2097
EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain), 2011. Scientiﬁc Opinion on the risks for
animal and public health related to the presence of T-2 and HT-2 toxin in food and feed. EFSA Journal 2011;9
(12):2481, 187 pp. https://doi.org/10.2903/j.efsa.2011.2481
EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain), 2012. Scientiﬁc Opinion on Ergot alkaloids
in food and feed. EFSA Journal 2012;10(7):2798, 158 pp. https://doi.org/10.2903/j.efsa.2012.2798
Franzmann C, Steinmeier A, Dittmer N and Humpf HU, 2010. Mutterkorn in Roggen – Vorkommen, Nachweis und
Stabilit€at der Mutterkornalkaloide. Cereal Technology, 4, 213–219.
Huybrechts ISI, Boon PE, Ruprich J, Lafay L, Turrini A, Amiano P, Hirvonen T, De Neve M, Arcella DMJ, Westerlund
A, Ribas-Barba L, Hilbig A, Papoutsou S, Christensen T, Oltarzewski MVS, Rehurkova I, Azpiri M, Sette S,
Kersting M, Walkiewicz A, Serra- Majem L VJ, Trolle E, Tornaritis M, Busk L, Kafatos A, Fabiansson S, De
Henauw S and JD VK, 2011. Dietary exposure assessments for children in Europe (the EXPOCHI project):
rationale, methods and design. Archives of Public Health, 69, 1169–1184.
Krska R and Crews C, 2008. Signiﬁcance, chemistry and determination of ergot alkaloids: a review. Food Additives
and Contaminants: Part A, 25, 722–731. https://doi.org/10.1080/02652030701765756
Leeson S and Summers JD, 2008. Commercial Poultry Nutrition, 3rd Edition. Nottingham University Press,
Thrumpton, Nottingham, 398 pp.
Mainka S, D€anicke S, B€ohme H, Uebersch€ar KH and Liebert F, 2007. On the alkaloid content of ergot (Claviceps
purpurea). Landbauforschung V€olkenrode, 1, 51–59.
Merkel S, Dib B, Maul R, K€oppen R, Koch M and Nehls I, 2012. Degradation and epimerization of ergot alkaloids
after baking and in vitro digestion. Analytical Bioanalytical Chemistry, 404, 2489–2497.
Merten C, Ferrari P, Bakker M, Boss A, Hearty A, Leclercq C, Lindtner O, Tlustos C, Verger P, Volatier JL and Arcella
D, 2011. Methodological characteristics of the national dietary surveys carried out in the European Union as
included in the European Food Safety Authority (EFSA) Comprehensive European Food Consumption Database.
Food Additives and Contaminants Part A, 28, 975–995.
Miedaner T and Geiger HH, 2015. Biology, Genetics, and Management of Ergot (Claviceps spp.) in Rye, Sorghum,
and Pearl Millet. Schardl CL, ed. Toxins, 7, 659–678. https://doi.org/10.3390/toxins7030659
Mulder PPJ, van Raamsdonk LWD, van Egmond HJ, Voogt J, van Brakel MW, van der Horst GM and de Jong J,
2012. Dutch survey ergot alkaloids and sclerotia in animal. RIKILT report 2012-005, 54 pp. Available online:
http://edepot.wur.nl/234699
Dietary exposure to ergot alkaloids
www.efsa.europa.eu/efsajournal 35 EFSA Journal 2017;15(7):4902
Mulder P, Pereboom-de Fauw D, Hoogenboom LAP, de Stoppelaar J and de Nijs M, 2015. Tropane and ergot
alkaloids in grain-based products for infants and young children in the Netherlands in 2011–2014. Food
Additives and Contaminants: Part B, 8, 284–290. https://doi.org/10.1080/19393210.2015.1089947
NRC (National Research Council), 2006. Nutrient Requirements of Dogs and Cats. National Academies Press,
Washington, DC, 424 pp.
NRC (National Research Council), 2007a. Nutrient Requirements of Small Ruminants: Sheep, Goats, Cervids and
New World Camelids. US National Academy of Science, Washington, DC, 360 pp.
NRC (National Research Council), 2007b. Nutrient Requirement of Horses. 6th Revised Edition. National Academies
Press, Washington, DC, 384 pp.
Scott PM, 2009. Ergot alkaloids: extent of human and animal exposure. World Mycotoxin Journal, 2, 141–149.
Speijers GJA, Wester PN, van Leeuwen FXR, de la Fonteyne-Blankestijn L, Post W, van Egmond HP, Sizoo EA and
Janssen GB, 1993. Subchronic toxicity experiment with rats fed a diet containing ergotamine tartrate. Report
no. 618312002. National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands.
Tittlemier SA, Drul D, Roscoe M and McKendry T, 2015. Occurrence of Ergot and Ergot alkaloids in western
Canadian wheat and other cereals. Journal of Agricultural and Food Chemistry, 63, 6644–6650. https://doi.org/
10.1021/acs.jafc.5b02977
Wegulo SN and Carlson MP, 2011. Ergot of small grain cereals and grasses and its health effects on humans and
livestock. University of Nebraska, Extension, EC1880. Available online: http://ianrpubs.unl.edu/live/ec1880/
build/ec1880.pdf
WHO/IPCS (World Health Organization/International Programme on Chemical Safety), 2009. Principles and
Methods for the Risk Assessment of Chemicals in Food, International Programme on Chemical Safety,
Environmental Health Criteria 240. Chapter 6: Dietary Exposure Assessment of Chemicals in Food. Available
online: http://www.who.int/ipcs/food/principles/en/index1.html
WHO-IPCS (World Health Organization-International Programme on Chemical Safety), 1990. Selected Mycotoxins:
Ochratoxins, Trichothecenes, Ergot. Environmental Health Criteria, Switzerland, 105 pp.
Wolff J and Richter W, 1989. Chemische Untersuchungen an Mutterkorn. Getreide, Mehl und Brot, 43, 103–107.
Wolff J, Neudecker C, Klug C and Weber R, 1988. Chemical and toxicologic studies of native corn in ﬂour and
bread. Zeitschrift f€ur Ernahrungswissenschaft, 27, 1–22.
Abbreviations
ARfD acute reference dose
BMDL10 benchmark dose at 10% extra risk
bw body weight
CI conﬁdence interval
Comprehensive Database EFSA Comprehensive European Food Consumption Database
CONTAM EFSA Panel on Contaminants in the Food Chain
EAs ergot alkaloids
FD ﬂuorescence detection
HBGV health-based guidance value
HPLC-FD high-performance liquid chromatography with ﬂuorescence detection
i.v. intravenous
LB lower bound
LC–MS/MS liquid chromatography–tandem mass spectrometry
LD50 lethal dose, median
LOD limit of detection
LOQ limit of quantiﬁcation
MB middle bound
ML maximum level
MS Member State
NOAEL no-observed-adverse-effect levels
RAC raw agricultural commodities
SSD Standard Sample Description
QqQ triple-quadrupole
TDI tolerable daily intake
UB upper bound
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Appendix A – Dietary surveys used to estimate chronic and acute dietary
exposure to ergot alkaloids in the European population
Appendix A can be found in the online version of this output under ‘Supporting information’.
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Appendix B – Intakes and composition of diets used to estimate animal
exposure to ergot alkaloids
The feed intake and the diet composition used to estimate the exposure to ergot alkaloids (EAs) of
the animal species considered in this report are those extensively described by the EFSA Panel on
Contaminants in the Food chain (CONTAM) in the Scientiﬁc Opinion on the risks for animal and public
health related to the presence of T-2 and HT-2 toxin in food and feed (EFSA CONTAM Panel, 2011).
They are summarised in this appendix. In addition, the diets for the farm livestock species and
companion animals include also the calculated lower-bound (LB) and upper-bound (UB) mean and high
concentrations for EAs, based on the LB and UB mean and high (P90–P95) concentrations in the
feedingstuff reported in Table 8.
B.1. Feed intake
B.1.1. Cattle, sheep, goats and horses
B.1.2. Pigs, poultry, ﬁsh and rabbit
Table B.1: Live weights, growth rate/productivity and dry matter intake for cattle, sheep, goats and
horses, and the proportions of the diet as non-forage
Live weight
(kg)
Growth rate or
productivity
Dry matter intake
(kg/day)
% of diet as
non-forage feed Reference
Dairy cows,
lactating
650 40 kg milk/day 20.7 60 AFRC (1993)
Beef:
fattening(a)
400 1 kg/day 9.6 20 AFRC (1993)
Beef: cereal 400 1.4 kg/day 8.4 85 AFRC (1993)
Sheep:
lactating
80 Feeding twin lambs 2.8 35 AFRC (1993)
Goats:
milking(b)
60 6 kg milk/day 3.4 75 NRC (2007a)
Goats:
fattening
40 0.2 kg/day 1.5 40 NRC (2007a)
Horses 450 – 9 50 NRC (2007b)
(a): Housed castrate cattle, medium maturing breed.
(b): Months 2–3 of lactation.
Table B.2: Live weights and feed intake for pigs, poultry, ﬁsh and rabbits
Live weight (kg) Feed intake (kg/day) Reference
Pigs: piglets 20 1.0 EFSA (2009a)
Pigs: fattening pigs 100 3.0 EFSA (2009a)
Pigs: lactating sows 200 6.0 EFSA (2009a)
Poultry: broilers 2 0.12 EFSA (2009a)
Poultry: laying hens 2 0.12 EFSA (2009a)
Turkeys: fattening turkeys 12 0.40 EFSA (2009a)
Ducks: fattening ducks 3 0.14 Leeson and Summers (2008)
Salmonids 2 0.04 EFSA (2009a)
Rabbit 2 0.15 Carabano and Piquer (1998)
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B.1.3. Dogs and cats
B.2. Diet composition and ergot alkaloids concentration estimates
B.2.1. Cattle sheep, goats and horses
B.2.2. Pigs and poultry
Table B.3: Live weights and feed intake for dogs and cats
Live weight (kg) Feed intake (kg/day) % of diet as cereal based feed Reference
Dogs 25 0.36 55 NRC (2006)
Cats 4 0.06 55 NRC (2006)
Table B.4: Compositions of non-forage feed for cattle, sheep and goats, and calculated mean and
high lower-bound and upper-bound levels of ergot alkaloids in these diets
Feeds
Dairy
cow
Beef
cattle
Beef cattle Sheep Goats Goats Horses
Cereal
beef
Fattening Lactating Dairy Fattening
Wheat (%) 15 14
Barley (%) 20 60 40 18 25 20
Oats (%) 35 40 40
Soybean meal (%) 5 5 10 10
Rapeseed meal (%) 20 5 20 10 10 10
Sunﬂower meal (%) 5 5
Beans (%) 5 10 10
Maize gluten feed (%) 10 10 11
Wheat feed (%) 10 4 10 15 10 10 30
Oat feed (%) 12
Sugar beet pulp (%) 8 10 12 15 2
Molasses (%) 3 2 3 4 4 3 5
Vegetable oils (%) 1 1 1 1 2 2
Minerals and vitamins (%) 3 3 3 3 4 3 3
Ergot alkaloids(a)
Mean lower bound (lg/kg) 76 61 657 83 57 55 88
Mean upper bound (lg/kg) 95 101 84 101 102 101 128
High lower bound (lg/kg) 246 304 262 272 266 253 338
High upper bound (lg/kg) 248 309 266 275 280 269 359
(a): Ergot alkaloid concentration present in the diets calculated by using the mean or the high concentrations reported for the
individual feeds (Table 8).
Table B.5: Diet compositions for pigs and poultry, and calculated mean and high lower-bound and
upper-bound levels of ergot alkaloids in these diets
Feeds Piglets
Pigs for
fattening
Lactating
sow Broilers
Laying
hens
Turkeys for
fattening
Ducks for
fattening
Wheat (%) 48 48 50 38 30 30 45
Barley (%) 20 20 11 35 15
Maize (%) 38 35
Soybean meal (%) 22 11 16 15 22 15 28
Rapeseed meal (%) 3 4
Lucerne meal (%) 4 9 5
Wheat feed (%) 9 14 1 7
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B.2.3. Rabbit
B.2.4. Fish
Feeds Piglets
Pigs for
fattening
Lactating
sow Broilers
Laying
hens
Turkeys for
fattening
Ducks for
fattening
Molasses (%) 3 4 4 3 3 3
Vegetable oils (%) 1 1 2 1 2 4
Minerals and vitamins (%) 3 3 3 4 4 4
Ergot alkaloids(a)
Mean lower bound (lg/kg) 136 156 164 96 74 105 140
Mean upper bound (lg/kg) 161 183 186 119 94 135 162
High lower bound (lg/kg) 328 401 410 196 148 306 347
High upper bound (lg/kg) 332 405 414 211 162 311 351
(a): Ergot alkaloid concentration present in the diets calculated by using the mean or the high concentrations reported for the
individual feeds (Table 8).
Table B.6: Diet composition for rabbits and calculated mean and high lower-bound and upper-
bound levels of ergot alkaloids
Feeds Rabbit
Sunﬂower meal (%) 20
Dried lucerne (%) 19
Wheat bran (%) 19
Barley (%) 18
Sugar beet pulp (%) 12
Beans (%) 11
Minerals and vitamins (%) 1
Ergot alkaloids(a)
Mean lower bound (lg/kg) 23
Mean upper bound (lg/kg) 40
High lower bound (lg/kg) 94
High upper bound (lg/kg) 109
(a): Ergot alkaloid concentration present in the diets calculated by using the mean or the high concentrations reported for the
individual feeds (Table 8).
Table B.7: Diet composition for salmonids and calculated mean and high lower-bound and upper-
bound levels of ergot alkaloids
Feeds Salmonids
Fishmeal (%) 30.5
Wheat (%) 13.2
Soybean meal (%) 12.3
Maize gluten feed (%) 11.5
Fish and vegetable oils (%) 31.9
Mineral vitamins premix (%) 0.6
Ergot alkaloids(a)
Mean lower bound (lg/kg) 33
Mean upper bound (lg/kg) 36
High lower bound (lg/kg) 65
High upper bound (lg/kg) 66
(a): Ergot alkaloid concentration present in the diets calculated by using the mean or the high concentrations reported for the
individual feeds (Table 8).
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B.2.5. Dogs and cats
Table B.8: Diet compositions for dogs and cats, and calculated mean and high lower-bound and
upper-bound levels of ergot alkaloids
Feeds Dogs Cats
Wheat (%) 30.5 30.5
Maize (%) 13.2 13.2
Barley (%) 12.3 12.3
Rice (%) 11.5 11.5
Maize gluten feed (%) 31.9 31.9
Ergot alkaloids(a)
Mean lower bound (lg/kg) 67 67
Mean upper bound (lg/kg) 140 140
High lower bound (lg/kg) 189 189
High upper bound (lg/kg) 247 247
(a): Ergot alkaloid concentration present in the diets calculated by using the mean or the high concentrations reported for the
individual feeds (Table 8).
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Appendix D – Detailed occurrence levels of ergot alkaloids in food
Appendix D can be found in the online version of this output under ‘Supporting information’.
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Appendix E – Chronic dietary exposure to ergot alkaloids in the European
population and contribution of different food commodities
Appendix E can be found in the online version of this output under ‘Supporting information’.
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Appendix F – Acute dietary exposure to ergot alkaloids in the European
population and contribution of different food commodities
Appendix F can be found in the online version of this output under ‘Supporting information’.
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Appendix G – Exposure assessment of ergot alkaloids for animals
G.1. Estimated intake of ergot alkaloids using mean LB and UB ergot
alkaloids concentrations in feedingstuffs
G.1.1. Dairy cows
G.1.2. Beef cattle
G.1.3. Sheep and goats
Table G.3: Estimated lower-bound and upper-bound exposure to ergot alkaloids by lactating sheep,
milking goats and fattening goats (lg/day and lg/kg bw per day)
Exposure
80-kg lactating sheep 60-kg milking goat 40-kg fattening goat
lg/day
Lower bound 91 146 33
Upper bound 111 261 60
lg/kg bw per day
Lower bound 1.14 2.43 0.82
Upper bound 1.38 4.35 1.51
bw: body weight.
Table G.1: Estimated lower-bound and upper-bound exposure by a 650-kg body weight lactating
dairy cow to ergot alkaloids at a milk production level of 40 milk/day and of non-forage
feed intake of 12 kg (DM) (lg/day and lg/kg bw per day)
Exposure
Milk Yield: 40 kg Non-forage feed consumed: 12 kg dry matter/day
lg/day
Lower bound 916
Upper bound 1,137
lg/kg bw per day
Lower bound 1.41
Upper bound 1.75
bw: body weight.
Table G.2: Estimated lower-bound and upper-bound exposure to ergot alkaloids by 400-kg body
weight fattening beef cattle reared on grass silage plus non-forage feeds system or a
cereal beef system (lg/day and lg/kg bw per day)
Exposure
Fattening beef Cereal beef
Non-forage feeds consumed (kg dry matter/day)
1.9 7.1
lg/day
Lower bound 123 497
Upper bound 184 821
lg/kg bw per day
Lower bound 0.31 1.24
Upper bound 0.46 2.05
bw: body weight.
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G.1.4. Pigs
G.1.5. Poultry
G.1.6. Rabbit
Table G.4: Estimated lower bound and upper-bound exposure of pigs to ergot alkaloids (lg/day
and lg/kg bw per day)
Exposure
Piglets Fattening pigs Lactating sows
lg/day
Lower bound 136.4 467.9 983.7
Upper bound 161.4 547.5 1,115.9
lg/kg bw per day
Lower bound 6.82 4.68 4.92
Upper bound 8.07 5.48 5.58
bw: body weight.
Table G.5: Estimated lower-bound and upper-bound exposure of poultry to ergot alkaloids (lg/day
and lg/kg bw per day)
Exposure
Broilers Laying hens Turkeys for fattening Ducks for fattening
lg/day
Lower bound 11.6 8.9 41.9 19.6
Upper bound 14.3 11.3 54.0 22.7
lg/kg bw per day
Lower bound 5.78 4.46 3.50 6.53
Upper bound 7.16 5.65 4.50 7.56
bw: body weight.
Table G.6: Estimated lower-bound and upper-bound exposure of a 2-kg body weight rabbit to
ergot alkaloids (lg/day and lg/kg bw per day)
Exposure
Rabbit
lg/day
Lower bound 3.49
Upper bound 5.96
lg/kg bw per day
Lower bound 1.74
Upper bound 2.98
bw: body weight.
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G.1.7. Farmed ﬁsh
G.1.8. Companion animals
G.2. Estimated intake of ergot alkaloids using high LB and UB ergot
alkaloids concentrations in feedingstuffs
G.2.1. Dairy cows
Table G.8: Estimated lower-bound and upper-bound exposure of a 25-kg body weight dog, a 4-kg
body weight cat and a 450-kg body weight horse to ergot alkaloids (lg/day and lg/kg
bw per day)
Exposure
Dogs Cats Horses
lg/day
Lower bound 13.27 2.21 394
Upper bound 27.72 4.62 574
lg/kg bw per day
Lower bound 0.53 0.55 0.88
Upper bound 1.11 1.16 1.28
bw: body weight.
Table G.7: Estimated lower-bound and upper-bound exposure of a 2-kg body weight salmon to
ergot alkaloids (lg/day and lg/kg bw per day)
Exposure
Salmon
lg/day
Lower-bound 1.31
Upper-bound 1.44
lg/kg bw per day
Lower-bound 0.65
Upper-bound 0.72
bw: body weight.
Table G.9: Estimated lower-bound and upper-bound exposure by a 650-kg body weight lactating
dairy cow to ergot alkaloids at a milk production level of 40 kg milk/day) and of non-
forage feed intake of 12 kg (DM) (lg/day, and lg/kg bw per day)
Exposure
Milk Yield: 40 kg Non-forage feed consumed: 12 kg dry matter/day
lg/day
Lower bound 2,947
Upper bound 2,980
lg/kg bw per day
Lower bound 4.53
Upper bound 4.58
bw: body weight.
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G.2.2. Beef cattle
G.2.3. Sheep and goats
G.2.4. Pigs
Table G.11: Estimated lower-bound and upper-bound exposure to ergot alkaloids by lactating
sheep, milking goats and fattening goats (lg/day and lg/kg bw per day)
Exposure
80-kg lactating sheep 60-kg milking goat 40-kg fattening goat
lg/day
Lower bound 299 677 152
Upper bound 302 715 162
lg/kg bw per day
Lower bound 3.74 11.28 3.80
Upper bound 3.78 11.91 4.04
bw: body weight.
Table G.10: Estimated lower-bound and upper-bound exposure to ergot alkaloids by 400-kg body
weight fattening beef cattle reared on grass silage plus non-forage feeds system or a
cereal beef system (lg/day and lg/kg bw per day)
Exposure
Fattening beef Cereal beef
Non-forage feeds consumed (kg dry matter/day)
1.9 7.1
lg/day
Lower bound 571 2,478
Upper bound 579 2,522
lg/kg bw per day
Lower bound 1.43 6.19
Upper bound 1.45 6.30
bw: body weight.
Table G.12: Estimated lower-bound and upper-bound exposure of pigs to ergot alkaloids (lg/day
and lg/kg bw per day)
Exposure
Piglets Fattening pigs Lactating sows
lg/day
Lower bound 327.5 1,201.5 2,461.6
Upper bound 332.2 1,215.6 2,485.5
lg/kg bw per day
Lower bound 16.38 12.02 12.31
Upper bound 16.61 12.16 12.43
bw: body weight.
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G.2.5. Poultry
G.2.6. Rabbit
G.2.7. Farmed ﬁsh
Table G.14: Estimated lower-bound and upper-bound exposure of a 2-kg body weight rabbit to
ergot alkaloids (lg/day and lg/kg bw per day)
Exposure
Rabbit
lg/day
Lower bound 14.09
Upper bound 16.38
lg/kg bw per day
Lower bound 7.04
Upper bound 8.19
bw: body weight.
Table G.15: Estimated lower-bound and upper-bound exposure of a 2-kg body weight salmon to
ergot alkaloids (lg/day and lg/kg bw per day)
Exposure
Salmon
lg/day
Lower bound 2.61
Upper bound 2.64
lg/kg bw per day
Lower bound 1.30
Upper bound 1.32
bw: body weight.
Table G.13: Estimated lower-bound and upper-bound exposure of poultry to ergot alkaloids (lg/
day and lg/kg bw per day)
Exposure
Broilers Laying hens Turkeys for fattening Ducks for fattening
lg/day
Lower bound 23.5 17.8 122.6 48.6
Upper bound 25.4 19.5 124.5 49.1
lg/kg bw per day
Lower bound 11.75 8.89 10.21 16.19
Upper bound 12.68 9.74 10.38 16.38
bw: body weight.
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G.2.8. Companion animals
G.3. Estimated intake of ergot alkaloids using mean or high LB and UB
ergot alkaloids concentrations in diets containing rye
G.3.1. Estimated intake using mean LB and UB ergot alkaloids
concentrations in feedingstuffs
Table G.16: Estimated lower-bound and upper-bound exposure of a 25-kg body weight dog, a 4-kg
body weight cat and a 450-kg body weight horse to ergot alkaloids (lg/day and lg/kg
bw per day)
Exposure
Dogs Cats Horses
lg/day
Lower bound 37.46 6.24 1,520
Upper bound 48.95 8.16 1,616
lg/kg bw per day
Lower bound 1.50 1.56 3.38
Upper bound 1.96 2.04 3.59
bw: body weight.
Table G.17: Estimated lower-bound and upper-bound exposure of pigs for fattening, lactating sows,
laying hens, dairy cows and beef fattening to ergot alkaloids from diets containing rye up
to the maximum recommended inclusion rate(a) (lg/day and lg/kg bw per day)
Inclusion
rate (%)
Diet concentration
lg/kg
Intake
lg/day
Intake
lg/kg bw
Pigs for fattening 50 LB 857 2,571 25.71
UB 882 2,647 26.47
Lactating sows 40 LB 597 3,582 17.91
UB 618 3,707 18.53
Laying hens 30 LB 333 40 19.95
UB 351 42 21.04
Dairy cows (40 kg milk) 25 LB 236 2,830 4.36
UB 253 3,036 4.67
Beef (fattening) 40 LB 520 1,133 2.83
UB 544 1,186 2.97
bw: body weight; LB: lower bound; UB: upper bound.
(a): Source: http://www.usask.ca/agriculture/plantsci/winter_cereals/winter_rye/Rye2.htm#livestock and www.usask.ca/agric
ulture/plantsci/winter_cereals
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G.3.2. Estimated intake using high LB and UB ergot alkaloids
concentrations in feedingstuffs
Table G.18: Estimated lower-bound and upper-bound exposure of pigs for fattening, lactating sows,
laying hens, dairy cows and beef fattening to ergot alkaloids from diets containing rye up
to the maximum recommended inclusion rate (lg/day and lg/kg bw per day)
Inclusion rate (%) Diet concentration
lg/kg
Intake
lg/day
Intake
lg/kg bw
Pigs for fattening 50 LB 2,240 6,718 67.19
UB 2,242 6,725 67.26
Lactating sows 40 LB 1,551 9,308 46.54
UB 1,554 9,322 46.61
Laying hens 30 LB 838 101 50.27
UB 848 102 50.86
Dairy cows (40 kg milk) 25 LB 694 8,328 12.81
UB 696 8,352 12.85
Beef (fattening) 40 LB 1,462 3,188 7.97
UB 1,464 3,192 7.98
bw: body weight; LB: lower bound; UB: upper bound.
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